<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" open-status="O" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><?release-delay 0|0 ?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Biol Chem</journal-id><journal-id journal-id-type="hwp">jbc</journal-id><journal-id journal-id-type="pmc">jbc</journal-id><journal-id journal-id-type="publisher-id">JBC</journal-id><journal-title-group><journal-title>The Journal of Biological Chemistry</journal-title></journal-title-group><issn pub-type="ppub">0021-9258</issn><issn pub-type="epub">1083-351X</issn><publisher><publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name><publisher-loc>9650 Rockville Pike, Bethesda, MD 20814, U.S.A.</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3057819</article-id><article-id pub-id-type="publisher-id">M110.165274</article-id><article-id pub-id-type="doi">10.1074/jbc.M110.165274</article-id><article-categories><subj-group subj-group-type="heading"><subject>Membrane Biology</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="7527" pm="."><plain>Activation of Colicin M by the FkpA Prolyl <italic>Cis-Trans</italic> Isomerase/Chaperone<xref ref-type="fn" rid="FN1">*</xref><xref ref-type="fn" rid="FN2"><sup><inline-graphic xlink:href="sbox.jpg"/></sup></xref> </plain></SENT>
</text></SecTag></article-title><alt-title alt-title-type="short">Cma Activation by FkpA</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Helbig</surname><given-names>Stephanie</given-names></name><xref ref-type="aff" rid="aff1"><sup>‡</sup></xref></contrib><contrib contrib-type="author"><name><surname>Patzer</surname><given-names>Silke I.</given-names></name><xref ref-type="aff" rid="aff1"><sup>‡</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schiene-Fischer</surname><given-names>Cordelia</given-names></name><xref ref-type="aff" rid="aff2"><sup>§</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zeth</surname><given-names>Kornelius</given-names></name><xref ref-type="aff" rid="aff1"><sup>‡</sup></xref></contrib><contrib contrib-type="author"><name><surname>Braun</surname><given-names>Volkmar</given-names></name><xref ref-type="aff" rid="aff1"><sup>‡</sup></xref><xref ref-type="corresp" rid="cor1"><sup>1</sup></xref></contrib><aff id="aff1">From the <label>‡</label>Max Planck Institute for Developmental Biology, Spemannstrasse 35, 72076 Tübingen, Germany and </aff><aff id="aff2">the <label>§</label>Max Planck Research Unit of Enzymology of Protein Folding, 06120 Halle, Germany</aff></contrib-group><author-notes><corresp id="cor1"><label>1</label> To whom correspondence should be addressed. Tel.: <phone>49-7071-601343</phone>; Fax: <fax>49-7071-601349</fax>; E-mail: <email>volkmar.braun@tuebingen.mpg.de</email>.</corresp></author-notes><pub-date pub-type="ppub"><day>25</day><month>2</month><year>2011</year></pub-date><pub-date pub-type="epub"><day>13</day><month>12</month><year>2010</year></pub-date><pub-date pub-type="pmc-release"><day>13</day><month>12</month><year>2010</year></pub-date><volume>286</volume><issue>8</issue><fpage>6280</fpage><lpage>6290</lpage><history><date date-type="received"><day>19</day><month>7</month><year>2010</year></date><date date-type="rev-recd"><day>12</day><month>11</month><year>2010</year></date></history><permissions><copyright-statement>© 2011 by The American Society for Biochemistry and Molecular Biology, Inc.</copyright-statement><license license-type="open-access"><license-p><italic>Author's Choice</italic>—Final version full access.</license-p><license-p><ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">Creative Commons Attribution Non-Commercial License</ext-link> applies to Author Choice Articles</license-p></license></permissions><self-uri xlink:title="pdf" xlink:type="simple" xlink:href="zbc00811006280.pdf"/><abstract><p><SecTag type="ABS"><text><SENT sid="7528" pm="."><plain>Colicin M (Cma) is specifically imported into the periplasm of <italic>Escherichia coli</italic> and kills the cells. </plain></SENT>
<SENT sid="7529" pm="."><plain>Killing depends on the periplasmic peptidyl prolyl <italic>cis-trans</italic> isomerase/chaperone FkpA. </plain></SENT>
<SENT sid="7530" pm="."><plain>To identify the Cma prolyl bonds targeted by FkpA, we replaced the 15 proline residues individually with alanine. </plain></SENT>
<SENT sid="7531" pm="."><plain>Seven mutant proteins were fully active; Cma(P129A), Cma(P176A), and Cma(P260A) displayed 1%, and Cma(P107A) displayed 10% of the wild-type activity. </plain></SENT>
<SENT sid="7532" pm="."><plain>Cma(P107A), Cma(P129A), and Cma(P260A), but not Cma(P176A), killed cells after entering the periplasm via osmotic shock, indicating that the former mutants were translocation-deficient; Cma(P129A) did not bind to the FhuA outer membrane receptor. </plain></SENT>
<SENT sid="7533" pm="."><plain>The crystal structures of Cma and Cma(P176A) were identical, excluding inactivation of the activity domain located far from Pro-176. </plain></SENT>
<SENT sid="7534" pm="."><plain>In a new peptidyl prolyl <italic>cis-trans</italic> isomerase assay, FkpA isomerized the Cma prolyl bond in peptide Phe-Pro-176 at a high rate, but Lys-Pro-107 and Leu-Pro-260 isomerized at only &lt;10% of that rate. </plain></SENT>
<SENT sid="7535" pm="."><plain>The four mutant proteins secreted into the periplasm via a fused signal sequence were toxic but much less than wild-type Cma. </plain></SENT>
<SENT sid="7536" pm="."><plain>Wild-type and mutant Cma proteins secreted or translocated across the outer membrane by energy-coupled import or unspecific osmotic shock were only active in the presence of FkpA. </plain></SENT>
<SENT sid="7537" pm="."><plain>We propose that Cma unfolds during transfer across the outer or cytoplasmic membrane and refolds to the active form in the periplasm assisted by FkpA. </plain></SENT>
<SENT sid="7538" pm="."><plain>Weak refolding of Cma(P176A) would explain its low activity in all assays. </plain></SENT>
<SENT sid="7539" pm="."><plain>Of the four proline residues identified as being important for Cma activity, Phe-Pro-176 is most likely targeted by FkpA. </plain></SENT>
</text></SecTag></p></abstract><SecTag type="KEYWORD"><kwd-group><kwd>Bacterial Toxins</kwd><kwd>Chaperone Chaperonin</kwd><kwd>Membrane Proteins</kwd><kwd>Protein Structure</kwd><kwd>Protein Translocation</kwd><kwd>Colicin</kwd><kwd>FkpA</kwd></kwd-group></SecTag></article-meta></front><body><SecTag type="INTRO"><sec sec-type="intro"><title><text><SENT sid="7540" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="7541" pm="."><plain>Colicin M (Cma)<xref ref-type="fn" rid="FN3"><sup>2</sup></xref> is synthesized by <italic>Escherichia coli</italic> cells that carry a pColBM plasmid and is unspecifically released to a low extent. </plain></SENT>
<SENT sid="7542" pm="."><plain>It kills sensitive <italic>E. coli</italic> cells by interfering with lipid carrier recycling, leading to inhibition of murein biosynthesis and cell lysis (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). </plain></SENT>
<SENT sid="7543" pm="."><plain>Specifically, Cma cleaves the phosphate ester bond between the lipid carrier (bactoprenol) and the murein precursor (<xref ref-type="bibr" rid="B3">3</xref>). </plain></SENT>
<SENT sid="7544" pm="."><plain>Cma enters the periplasm of sensitive cells by binding to the FhuA outer membrane receptor protein and translocation across the outer membrane by an energy-coupled mechanism through the action of the TonB, ExbB, and ExbD proteins (Ton system) (<xref ref-type="bibr" rid="B4">4</xref><xref ref-type="bibr" rid="B5">–</xref><xref ref-type="bibr" rid="B6">6</xref>). </plain></SENT>
</text></p><p><text><SENT sid="7545" pm="."><plain>Like all colicins, Cma consists of a central receptor binding domain, an N-terminal translocation domain, and a C-terminal activity domain (<xref ref-type="bibr" rid="B7">7</xref>), which can be seen in the crystal structure (<xref ref-type="bibr" rid="B8">8</xref>). </plain></SENT>
<SENT sid="7546" pm="."><plain>Only the activity domain, which starts at residue 124, is homologous with colicin-M-like proteins of other bacteria (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>). </plain></SENT>
</text></p><p><text><SENT sid="7547" pm="."><plain>The first <italic>E. coli</italic> mutants identified that were resistant to added colicin M were mutated in the <italic>fhuA</italic>, <italic>tonB</italic>, <italic>exbB</italic>, or <italic>exbD</italic> transport genes. </plain></SENT>
<SENT sid="7548" pm="."><plain>Another type of Cma-resistant mutant eluded genetic and function characterization (<xref ref-type="bibr" rid="B10">10</xref>) until recently. </plain></SENT>
<SENT sid="7549" pm="."><plain>We localized the mutation to the <italic>fkpA</italic> gene, which encodes a periplasmic peptidyl prolyl <italic>cis-trans</italic> isomerase (PPIase)/chaperone. </plain></SENT>
<SENT sid="7550" pm="."><plain>Among 10 colicins tested, only Cma requires FkpA for toxicity (<xref ref-type="bibr" rid="B11">11</xref>). </plain></SENT>
</text></p><p><text><SENT sid="7551" pm="."><plain>The function of FkpA for <italic>E. coli</italic> physiology, however, is not clear as <italic>fkpA</italic> mutants show no phenotype. </plain></SENT>
<SENT sid="7552" pm="."><plain>FkpA is overexpressed under stress conditions, partially controlled by σ<sup>E</sup> through a σ<sup>E</sup> promoter. </plain></SENT>
<SENT sid="7553" pm="."><plain>Deletion of <italic>fkpA</italic> stimulates transcription of <italic>degP</italic>, which encodes a heat shock-inducible periplasmic protease (<xref ref-type="bibr" rid="B12">12</xref>). </plain></SENT>
<SENT sid="7554" pm="."><plain>Overproduction of FkpA prevents the formation of periplasmic inclusion bodies of MalE31, a defective folding derivative of the MalE-binding protein (<xref ref-type="bibr" rid="B13">13</xref>), and increases the yield of functional engineered antibody fragments produced in <italic>E. coli</italic> (<xref ref-type="bibr" rid="B14">14</xref>). </plain></SENT>
</text></p><p><text><SENT sid="7555" pm="."><plain>FkpA displays high PPIase activity, as demonstrated by the refolding of ribonuclease T1 and prolyl <italic>cis-trans</italic> isomerization of oligopeptides (<xref ref-type="bibr" rid="B15">15</xref>). </plain></SENT>
<SENT sid="7556" pm="."><plain>Its activity is inhibited by FK506, an inhibitor of prokaryotic and eukaryotic FKBP-type PPIases (<xref ref-type="bibr" rid="B15">15</xref>). </plain></SENT>
<SENT sid="7557" pm="."><plain>FkpA forms a dimer; the monomers consist of an N-proximal helical domain (residues 1–114) and a C-proximal domain (residues 115–245) typical for the FKBP family of PPIases (<xref ref-type="bibr" rid="B16">16</xref>). </plain></SENT>
<SENT sid="7558" pm="."><plain>The five periplasmic PPIases/chaperones PpiA, PpiD, SurA, FkpA, and Skp usually act on various substrates and can functionally replace each other (<xref ref-type="bibr" rid="B17">17</xref><xref ref-type="bibr" rid="B18">–</xref><xref ref-type="bibr" rid="B19">19</xref>). </plain></SENT>
<SENT sid="7559" pm="."><plain>In contrast, the toxicity of Cma strictly depends on FkpA and not on any other <italic>E. coli</italic> PPIase/chaperone (<xref ref-type="bibr" rid="B11">11</xref>). </plain></SENT>
</text></p><p><text><SENT sid="7560" pm="."><plain>The strict dependence of Cma toxicity on FkpA prompted us to attempt to identify the prolyl bond targeted by FkpA. </plain></SENT>
<SENT sid="7561" pm="."><plain>If periplasmic Cma activity depends on the FkpA prolyl <italic>cis-trans</italic> isomerase function and not, or not only on the FkpA chaperone function, replacement of the proline residue that is <italic>cis-trans</italic>-isomerized should prevent activation. </plain></SENT>
<SENT sid="7562" pm="."><plain>To test this premise we replaced each of the 15 proline residues in Cma individually with alanine. </plain></SENT>
<SENT sid="7563" pm="."><plain>Here we identified one prolyl bond that could serve as the target of FkpA PPIase catalysis. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec sec-type="methods"><title><text><SENT sid="7564" pm="."><plain>EXPERIMENTAL PROCEDURES </plain></SENT>
</text></title><sec><title/><sec><title/><sec><title><text><SENT sid="7565" pm="."><plain>Bacterial Strains and Plasmids </plain></SENT>
</text></title><p><text><SENT sid="7566" pm="."><plain>The bacterial strains and plasmids used and their sources are listed in <xref ref-type="table" rid="T1">Table 1</xref>. </plain></SENT>
<SENT sid="7567" pm="."><plain>Isolation of the FkpA313 mutant SIP1275 and the temperature-sensitive FkpA43 mutant K458 was described previously (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B20">20</xref>). </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="T1" position="float"><label>TABLE 1</label><caption><p><text><SENT sid="7568" pm="."><plain><bold><italic>E. coli</italic> strains and plasmids used in this study</bold> </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead valign="bottom"><tr><th align="center" rowspan="1" colspan="1"><text><SENT sid="7569" pm="."><plain>Strain/Plasmid </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="7570" pm="."><plain>Genotype </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="7571" pm="."><plain>Reference </plain></SENT>
</text></th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7572" pm="."><plain><bold>Strain</bold> </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7573" pm="."><plain>    AB2847 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7574" pm="."><plain><italic>aroB thi tsx malT</italic> </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7575" pm="."><plain>(<xref ref-type="bibr" rid="B1">1</xref>) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7576" pm="."><plain>    BL21(DE3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7577" pm="."><plain>F<sup>−</sup><italic>ompT gal dcm lon hsd<sub>B</sub></italic> (<italic>r<sub>B</sub><sup>−</sup> m<sub>B</sub><sup>−</sup></italic>) λ(DE3) <italic>lacI lacUV5</italic>-T7 gene 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7578" pm="."><plain>(<xref ref-type="bibr" rid="B50">50</xref>) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7579" pm="."><plain>    BL21 <italic>fhuA</italic> </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7580" pm="."><plain>BL21(DE3) <italic>fhuA</italic> </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7581" pm="."><plain>(<xref ref-type="bibr" rid="B11">11</xref>) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7582" pm="."><plain>    MB97 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7583" pm="."><plain>AB2847 Δ<italic>fhuA</italic> </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7584" pm="."><plain>(<xref ref-type="bibr" rid="B54">54</xref>) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7585" pm="."><plain>    K458 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7586" pm="."><plain>AB2847 <italic>fkpA43</italic> (<italic>tolM-</italic>ts) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7587" pm="."><plain>(<xref ref-type="bibr" rid="B20">20</xref>) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7588" pm="."><plain>    Mo3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7589" pm="."><plain>AB2847 <italic>fkpA40</italic> </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7590" pm="."><plain>(<xref ref-type="bibr" rid="B10">10</xref>) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7591" pm="."><plain>    ES965 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7592" pm="."><plain>KTu50 pES7 <italic>cba cbi</italic> on pACYC184 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7593" pm="."><plain>(<xref ref-type="bibr" rid="B51">51</xref>) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7594" pm="."><plain>    DH5α </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7595" pm="."><plain><italic>supE44</italic> Δ<italic>lacU169</italic> [Φ80<italic>lacZ</italic>Δ<italic>M15</italic>] <italic>hsdR17 recA1 endA1 gyrA thi-1 relA1</italic> </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7596" pm="."><plain>(<xref ref-type="bibr" rid="B52">52</xref>) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7597" pm="."><plain>    SIP1275 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7598" pm="."><plain>AB2847 <italic>fkpA313</italic> </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7599" pm="."><plain>(<xref ref-type="bibr" rid="B11">11</xref>) </plain></SENT>
</text></td></tr><tr><td colspan="3" rowspan="1"><text><SENT sid="7600" pm="."><plain><hr/> </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7601" pm="."><plain><bold>Plasmid</bold> </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7602" pm="."><plain>    pMLD237 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7603" pm="."><plain><italic>cma</italic> encoding Cma-His<xref ref-type="table-fn" rid="TF1-1"><italic><sup>a</sup></italic></xref> </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7604" pm="."><plain>(<xref ref-type="bibr" rid="B3">3</xref>) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7605" pm="."><plain>    pSP127/56 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7606" pm="."><plain>pET25b encoding FkpA313-His<xref ref-type="table-fn" rid="TF1-2"><italic><sup>b</sup></italic></xref> </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7607" pm="."><plain>(<xref ref-type="bibr" rid="B11">11</xref>) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7608" pm="."><plain>    pYH15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7609" pm="."><plain>pET25b encoding FkpA-His<xref ref-type="table-fn" rid="TF1-2"><italic><sup>b</sup></italic></xref> </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7610" pm="."><plain>(<xref ref-type="bibr" rid="B11">11</xref>) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7611" pm="."><plain>    pYH16 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7612" pm="."><plain>pET25b encoding FkpA43-His<xref ref-type="table-fn" rid="TF1-2"><italic><sup>b</sup></italic></xref> </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7613" pm="."><plain>(<xref ref-type="bibr" rid="B11">11</xref>) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7614" pm="."><plain>    pGP1–2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7615" pm="."><plain>Gene 1 (T7 polymerase) behind λP<sub>L</sub> controlled by the temperature-sensitive <italic>C</italic>I857 λ repressor </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7616" pm="."><plain>(<xref ref-type="bibr" rid="B53">53</xref>) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7617" pm="."><plain>    pPG773 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7618" pm="."><plain>pT7–7 <italic>pbpB-cmi</italic>, Ap<sup>R</sup> encoding PbpB′-′Cmi </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7619" pm="."><plain>(<xref ref-type="bibr" rid="B33">33</xref>) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7620" pm="."><plain>    pSP130/155 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7621" pm="."><plain>encodes MalE1–26-Cma1–271 with a C-terminal His-tag controlled by the <italic>araBAD</italic> promoter, <italic>araC</italic>, Ap<sup>r</sup> </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7622" pm="."><plain>This study </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn id="TF1-1"><p><text><SENT sid="7623" pm="."><plain><italic><sup>a</sup></italic> Cma with a N-terminal His<sub>6</sub> tag. </plain></SENT>
</text></p></fn><fn id="TF1-2"><p><text><SENT sid="7624" pm="."><plain><italic><sup>b</sup></italic> FkpA protein with a C-terminal His<sub>6</sub> tag. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag></sec><sec><title><text><SENT sid="7625" pm="."><plain>Generation of Cma Proline Substitution Mutants </plain></SENT>
</text></title><p><text><SENT sid="7626" pm="."><plain>The <italic>cma</italic> gene on plasmid pMLD237 (generously provided by D. </plain></SENT>
<SENT sid="7627" pm="."><plain>Mengin-Lecreulx, Université Paris-Sud, Orsay, France) encodes Cma with an N-terminal His<sub>6</sub> tag. </plain></SENT>
<SENT sid="7628" pm="."><plain>We replaced each of the 15 proline residues in Cma with alanine by site-directed mutagenesis of <italic>cma</italic> with appropriate primers (sequences available upon request) using the QuickChange® site-directed mutagenesis kit (Stratagene, La Jolla, CA) and the Phusion<sup>TM</sup> high fidelity DNA polymerase (Finnzymes, Espoo, Finland). </plain></SENT>
<SENT sid="7629" pm="."><plain>Mutagenized <italic>cma</italic> genes on plasmid pMLD237 were introduced into <italic>E. coli</italic> DH5α by transformation, and the mutations were verified by sequencing the <italic>cma</italic> genes isolated from the transformants. </plain></SENT>
<SENT sid="7630" pm="."><plain>Cma activity was determined with transformants of <italic>E. coli</italic> BL21 <italic>fkpA</italic> carrying the mutated <italic>cma</italic> genes on pMLD237. </plain></SENT>
<SENT sid="7631" pm="."><plain>For the assay, crude cell extracts were serially diluted 10-fold, and 10 μl were spotted on LB agar plates seeded with <italic>E. coli</italic> AB2847. </plain></SENT>
<SENT sid="7632" pm="."><plain>The same procedure was used to isolate the mutant Cma(D226A). </plain></SENT>
</text></p><p><text><SENT sid="7633" pm="."><plain>To equip Cma with a signal sequence, <italic>cma</italic> on pMLD237 was amplified by PCR, ligated to a sequence encoding a C-terminal His-tag, and cloned downstream of <italic>malE′</italic> of pMA-RQ MalE′-Cma1–130 synthesized by Geneart (Regensburg, Germany), replacing <italic>cma1–130</italic>. </plain></SENT>
<SENT sid="7634" pm="."><plain>The resulting plasmid pSP130/155 encodes the signal sequence MalE1–26 (Swissprot P0AEX9), Cma1–271 (Swissprot P05820) and the C-terminal His-tag LAHHHHHH under the control of the <italic>araBAD</italic> promoter. </plain></SENT>
<SENT sid="7635" pm="."><plain>The plasmid contains <italic>araC</italic> from pMA-RQ MalE′-Cma(1–130). </plain></SENT>
<SENT sid="7636" pm="."><plain>pSP130/155 was mutagenized by site-directed mutagenesis, resulting in plasmids encoding MalE′-Cma(P107A)-His, MalE′-Cma(P129A)-His, MalE′-Cma(P176A)-His, MalE′-Cma(D226A)-His, and MalE′-Cma(P260A)-His. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="7637" pm="."><plain>Isolation of Cma and Mutant Cma </plain></SENT>
</text></title><p><text><SENT sid="7638" pm="."><plain>Cma and the proteins from transformants of <italic>E. coli</italic> BL21(DE3) <italic>fkpA</italic> harboring the recombinant plasmids were purified on Ni-NTA-agarose as described previously (<xref ref-type="bibr" rid="B11">11</xref>), taking advantage of the His<sub>6</sub> tag on the proteins. <italic>E. coli</italic> BL21(DE3) <italic>fkpA</italic> is not killed by Cma because of the <italic>fkpA</italic> mutation. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="7639" pm="."><plain>Isolation of Colicin B and Competition Assays </plain></SENT>
</text></title><p><text><SENT sid="7640" pm="."><plain>A crude extract of colicin B was isolated from <italic>E. coli</italic> ES965 (pES7 <italic>cba cbi</italic>). </plain></SENT>
<SENT sid="7641" pm="."><plain>Synthesis of colicin B was induced by adding 0.4 μg ml<sup>−1</sup> mitomycin C in water to the culture and shaking the culture for 150 min at 37 °C. </plain></SENT>
<SENT sid="7642" pm="."><plain>Cells were harvested and suspended in 0.1 <sc>m</sc> Tris-HCl, pH 7.5, and disrupted by sonication, and the suspension was centrifuged. </plain></SENT>
<SENT sid="7643" pm="."><plain>The soluble fraction containing colicin B was active up to a dilution of 10<sup>6</sup> and was used for competition assays with Cma and the nearly inactive Cma proline mutants. </plain></SENT>
<SENT sid="7644" pm="."><plain>For the assays, exponentially growing cells of <italic>E. coli</italic> Mo3 <italic>fkpA40</italic> were supplemented with a Cma sample and incubated for 10 min; colicin B at a final dilution titer of 10<sup>4</sup> was then added. </plain></SENT>
<SENT sid="7645" pm="."><plain>Growth of the cultures was monitored spectrophotometrically for 5 h. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="7646" pm="."><plain>Isolation of FkpA-His<sub>6</sub> </plain></SENT>
</text></title><p><text><SENT sid="7647" pm="."><plain>FkpA-His<sub>6</sub> was isolated from cells of <italic>E. coli</italic> BL21(DE3) <italic>fkpA</italic> transformed with pYH15 <italic>fkpA</italic> and purified on Ni-NTA-agarose as described (<xref ref-type="bibr" rid="B11">11</xref>). </plain></SENT>
<SENT sid="7648" pm="."><plain>The eluate of the column was concentrated with Amicon ultra-15 tubes, and FkpA was further purified by chromatography on a 320-ml Superdex 75 column with 35 m<sc>m</sc> HEPES, pH 7.8. </plain></SENT>
<SENT sid="7649" pm="."><plain>The presence of the desired proteins and impurities in the eluted fractions were analyzed by SDS-PAGE. </plain></SENT>
<SENT sid="7650" pm="."><plain>FkpA313-His and FkpA43-His from cells transformed with plasmids pSP127/56 and pYH16, respectively, were isolated accordingly to electrophoretic homogeneity. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="7651" pm="."><plain>Crystallization, Data Collection, Phasing, and Refinement </plain></SENT>
</text></title><p><text><SENT sid="7652" pm="."><plain>Crystallization of initial protein crystals were obtained by sitting-drop crystallization with screens purchased from Qiagen mixing 0.4 μl of protein with 0.4 μl of reservoir solution. </plain></SENT>
<SENT sid="7653" pm="."><plain>Drops were prepared using the Honeybee 961 crystallization robot (Genomic Solutions) and automatically imaged using the Rock Imager 54 imaging system (Formulatrix, Waltham). </plain></SENT>
<SENT sid="7654" pm="."><plain>Crystals of wild-type (wt) and mutant proteins were mounted from the crystallization drops and frozen in liquid nitrogen according to the procedure described in <xref ref-type="table" rid="T3">Table 3</xref>. </plain></SENT>
<SENT sid="7655" pm="."><plain>Data of wt and mutant crystals were collected either at beamline PXII, Swiss Light Source, or beamline ID29 of the European Synchrotron Radiation Facility. </plain></SENT>
<SENT sid="7656" pm="."><plain>Diffraction images were recorded on the detector types mentioned in <xref ref-type="table" rid="T3">Table 3</xref>. </plain></SENT>
<SENT sid="7657" pm="."><plain>All diffraction images were processed and scaled with the XDS/XCALE program package (<xref ref-type="bibr" rid="B21">21</xref>). </plain></SENT>
<SENT sid="7658" pm="."><plain>The structure of the wt crystals was solved by molecular replacement using the MOLREP program starting from the PDB entry <ext-link ext-link-type="pdb" xlink:href="3DA4">3DA4</ext-link> (MOLREP). </plain></SENT>
<SENT sid="7659" pm="."><plain>Structures of the two mutant datasets were solved using the wt structure and the program MOLREP. </plain></SENT>
<SENT sid="7660" pm="."><plain>Model building and refinement of all structures was performed in CCP4i (<xref ref-type="bibr" rid="B22">22</xref>) and Coot (<xref ref-type="bibr" rid="B23">23</xref>). </plain></SENT>
<SENT sid="7661" pm="."><plain>Protein geometry was analyzed using the program PROCHECK (<xref ref-type="bibr" rid="B24">24</xref>), and secondary structures were assigned based on the DSSP algorithm (<xref ref-type="bibr" rid="B25">25</xref>). </plain></SENT>
<SENT sid="7662" pm="."><plain>All pictures were prepared using the PYMOL program. </plain></SENT>
<SENT sid="7663" pm="."><plain>Statistics are summarized in <xref ref-type="table" rid="T3">Table 3</xref>. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="7664" pm="."><plain>Cma Sensitivity Tests </plain></SENT>
</text></title><p><text><SENT sid="7665" pm="."><plain>Sensitivity of <italic>E. coli</italic> cells to Cma was tested with Cma, and mutant derivatives were purified to electrophoretic homogeneity by Ni-NTA-agarose chromatography or with crude extracts of cells that overexpressed Cma or mutant derivatives. </plain></SENT>
<SENT sid="7666" pm="."><plain>In the latter case the Cma protein was by far the most prominent protein in the cell extract, as revealed by SDS-PAGE. </plain></SENT>
<SENT sid="7667" pm="."><plain>The <italic>cma</italic> transformants released less than 10% of the Cma produced as they lack a Cma lysis gene, which is also absent on natural pColBM plasmids (<xref ref-type="bibr" rid="B26">26</xref>). </plain></SENT>
<SENT sid="7668" pm="."><plain>Cells from an 8-ml culture were harvested by centrifugation and suspended in 0.5 ml of 0.1 <sc>m</sc> Tris-HCl, pH 7.5. </plain></SENT>
<SENT sid="7669" pm="."><plain>An aliquot of 0.2 ml was disrupted by vigorously shaking with glass beads, and cell debris was removed by centrifugation (16,000 × <italic>g</italic>, 4 °C). </plain></SENT>
<SENT sid="7670" pm="."><plain>10-Fold dilutions of Cma were spotted onto 20 ml of LB agar plates seeded with 10<sup>9</sup> cells of the strains to be tested in 3 ml of soft agar. </plain></SENT>
<SENT sid="7671" pm="."><plain>The results are given as the diameter (in mm) of the clear zone of growth inhibition. </plain></SENT>
</text></p><p><text><SENT sid="7672" pm="."><plain>To examine the sensitivity of cells overexpressing FkpA, we used <italic>E. coli</italic> BL21(DE3) <italic>fkpA</italic> transformed with both pYH15 <italic>fkpA</italic> and pGP1-2, which encodes the T7 polymerase gene 1 behind λP<sub>L</sub>, controlled by the temperature-sensitive <italic>C</italic>I857 λ repressor. </plain></SENT>
<SENT sid="7673" pm="."><plain>Cells were grown at 30 °C to an <italic>A</italic><sub>578 nm</sub> of 0.3 and then shifted for 150 min to 42 °C. </plain></SENT>
<SENT sid="7674" pm="."><plain>10-Fold-diluted Cma samples were spotted onto LB plates seeded with temperature-induced <italic>E. coli</italic> BL21(DE3) <italic>fkpA</italic> (pYH15 <italic>fkpA</italic> pGP1-2) and incubated overnight at 37 °C. </plain></SENT>
<SENT sid="7675" pm="."><plain>The diameter of the lysis zone was measured. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="7676" pm="."><plain>Osmotic Shock </plain></SENT>
</text></title><p><text><SENT sid="7677" pm="."><plain>Osmotic shock not only releases periplasmic proteins into the shock medium (<xref ref-type="bibr" rid="B27">27</xref>) but also transfers added proteins into the periplasm (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>). </plain></SENT>
<SENT sid="7678" pm="."><plain>The Cma sensitivity of cells after osmotic shock was tested with purified Cma samples. </plain></SENT>
</text></p><p><text><SENT sid="7679" pm="."><plain><italic>E. coli</italic> AB2847 in 10 ml of LB medium was grown to an <italic>A</italic><sub>578 nm</sub> of 0.5; cells were harvested by centrifugation and then suspended in 1 ml of 10 m<sc>m</sc> Tris-HCl, 30 m<sc>m</sc> NaCl, pH 7 (buffer 1). </plain></SENT>
<SENT sid="7680" pm="."><plain>Cells were pelleted by centrifugation, washed once with buffer 1, and centrifuged again. </plain></SENT>
<SENT sid="7681" pm="."><plain>The washed cells were suspended in 0.5 ml of 33 m<sc>m</sc> Tris-HCl, pH 7 (buffer 2), and 0.1-ml aliquots were added to four tubes. </plain></SENT>
<SENT sid="7682" pm="."><plain>Sucrose (40% in buffer 2, 0.1 ml) was added to two tubes, and buffer 2 (0.1 ml) was added to the other two tubes. </plain></SENT>
<SENT sid="7683" pm="."><plain>Cells were suspended by vortexing, kept for 10 min on a shaker, then cooled from room temperature to 4 °C and harvested by centrifugation. </plain></SENT>
<SENT sid="7684" pm="."><plain>Cma (10 μg in 10 μl) was added to an Eppendorf tube containing a cell suspension treated with sucrose and a tube containing an untreated cell suspension. </plain></SENT>
<SENT sid="7685" pm="."><plain>Then 0.2 ml of ice-cold 0.5 m<sc>m</sc> MgCl<sub>2</sub> and 30 μl of 1 m<sc>m</sc> CaCl<sub>2</sub> was added to each tube; the <italic>in vivo</italic> activity of Cma depends on Ca<sup>2+</sup> (<xref ref-type="bibr" rid="B20">20</xref>). </plain></SENT>
<SENT sid="7686" pm="."><plain>The contents of the tubes were immediately mixed by vortexing. </plain></SENT>
<SENT sid="7687" pm="."><plain>Two additional samples received no Cma but were otherwise treated the same way. </plain></SENT>
<SENT sid="7688" pm="."><plain>The four samples were kept on ice for 15 min and then serially diluted 10-fold in buffer 2. </plain></SENT>
<SENT sid="7689" pm="."><plain>Aliquots of 0.1 ml were suspended in 3 ml of LB soft agar and spread on 20-ml LB agar plates. </plain></SENT>
<SENT sid="7690" pm="."><plain>After overnight incubation at 37 °C, the colonies were counted. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="7691" pm="."><plain>Activity Assay for Secreted Cma </plain></SENT>
</text></title><p><text><SENT sid="7692" pm="."><plain>Cells containing wild-type <italic>cma</italic> and <italic>cma</italic> mutant genes fused to the MalE signal sequence were grown in LB medium containing ampicillin to the exponential growth phase. </plain></SENT>
<SENT sid="7693" pm="."><plain>Arabinose was added to the final concentrations indicated in <xref ref-type="fig" rid="F4">Fig. 4</xref>. </plain></SENT>
<SENT sid="7694" pm="."><plain>To avoid killing of cells by Cma released into the medium, transformants of the <italic>fhuA</italic> mutant MB97 were used. </plain></SENT>
<SENT sid="7695" pm="."><plain>In the case of <italic>fkpA</italic> mutants this precaution was not required as they are resistant to Cma. </plain></SENT>
<SENT sid="7696" pm="."><plain>Cell growth and lysis were monitored by measuring the optical density at 578 nm. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="7697" pm="."><plain>Determination of PPIase Activity in Vitro </plain></SENT>
</text></title><p><text><SENT sid="7698" pm="."><plain>The <italic>cis-trans</italic> isomerization of the peptides <italic>p</italic>-aminobenzoyl-CF<underline>P</underline>VC-(NO<sub>2</sub>)Tyr-NH<sub>2</sub> (<underline>P</underline> is Pro-176), <italic>p</italic>-aminobenzoyl-CK<underline>P</underline>)AC-(NO<sub>2</sub>)Tyr-NH<sub>2</sub> (<underline>P</underline> is Pro-107), and <italic>p</italic>-aminobenzoyl-CL<underline>P</underline>GC-(NO<sub>2</sub>)Tyr-NH<sub>2</sub> (<underline>P</underline> is Pro-260) was induced by reducing the disulfide bond with 50 m<sc>m</sc> DTT in 35 m<sc>m</sc> HEPES, pH 7.8. </plain></SENT>
<SENT sid="7699" pm="."><plain>The time course of fluorescence of 1 μ<sc>m</sc> concentrations of each peptide at 10 °C was followed at 420 nm after the peptides were transferred from the peptide stock solution in DMSO to the final buffer solution. </plain></SENT>
<SENT sid="7700" pm="."><plain>The excitation wavelength was 320 nm, and the spectral bandwidth was 5 nm. </plain></SENT>
<SENT sid="7701" pm="."><plain>Data were analyzed by single exponential nonlinear regression using a Sigma Plot Scientific Graphing System. </plain></SENT>
<SENT sid="7702" pm="."><plain>The samples contained 31–124 μ<sc>m</sc> of FkpA and its derivatives. <italic>k</italic><sub>cat</sub>/<italic>K<sub>m</sub></italic> was determined by evaluating the linear dependence of <italic>k</italic><sub>enz</sub> from the concentration of FkpA and its derivatives. <italic>k</italic><sub>enz</sub> is the catalyzed first-order rate minus the uncatalyzed rate. <italic>k</italic><sub>cat</sub>/<italic>K<sub>m</sub></italic> was calculated from <italic>k</italic><sub>enz</sub>/<italic>E<sub>o</sub></italic>, where <italic>E<sub>o</sub></italic> is the FkpA concentration. </plain></SENT>
<SENT sid="7703" pm="."><plain>Each data point represents the mean of three independent measurements that differed less than 10%. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="7704" pm="."><plain>Cleavage of Cma by Proteinase K </plain></SENT>
</text></title><p><text><SENT sid="7705" pm="."><plain>Cma and its derivatives tagged with His<sub>6</sub> at the N terminus were purified on Ni-NTA-agarose; 20 μg of each protein was incubated with 0.01 μg of proteinase K for 13 min on ice and then analyzed by SDS-PAGE. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="7706" pm="."><plain>Circular Dichroism (CD) </plain></SENT>
</text></title><p><text><SENT sid="7707" pm="."><plain>CD spectra of electrophoretically homogeneous wild-type and mutant Cma proteins were recorded in a Jasco spectral polarimeter model J-810 at 190–240 nm and 20 °C. </plain></SENT>
<SENT sid="7708" pm="."><plain>Temperature-dependent denaturation was measured at 220 nm between 10 and 70 °C. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="7709" pm="."><plain>Denaturation of Cma and Cma Mutants by Urea </plain></SENT>
</text></title><p><text><SENT sid="7710" pm="."><plain>Proteins (1 mg ml<sup>−1</sup>) dissolved in 20 m<sc>m</sc> potassium phosphate, 0.5 m<sc>m</sc> MgCl<sub>2</sub>, 2 m<sc>m</sc> mercaptoethanol, 150 m<sc>m</sc> NaCl, or in the same buffer containing 1–8 M urea were incubated for 15 min at 20 °C. </plain></SENT>
<SENT sid="7711" pm="."><plain>The samples were centrifuged, and the fluorescence emission spectrum was measured between 300 and 500 nm (1 nm bandwidth), with excitation at 280 nm (3 nm bandwidth) in a Jasco spectrofluorometer FP-6500. </plain></SENT>
<SENT sid="7712" pm="."><plain>The values given are the average of five determinations. </plain></SENT>
</text></p></sec></sec></sec></sec></SecTag><SecTag type="RESULTS"><sec sec-type="results"><title><text><SENT sid="7713" pm="."><plain>RESULTS </plain></SENT>
</text></title><sec><title/><sec><title/><sec><title><text><SENT sid="7714" pm="."><plain>Isolation of Pro → Ala Colicin M (Cma) Mutants </plain></SENT>
</text></title><p><text><SENT sid="7715" pm="."><plain>We previously have shown that FkpA is required for killing <italic>E. coli</italic> K-12 by Cma (<xref ref-type="bibr" rid="B11">11</xref>). </plain></SENT>
<SENT sid="7716" pm="."><plain>If periplasmic Cma activity depends on the FkpA prolyl <italic>cis-trans</italic> isomerase function and not, or not only on the FkpA chaperone function, replacement of the proline residue that is <italic>cis-trans</italic>-isomerized should prevent activation. </plain></SENT>
<SENT sid="7717" pm="."><plain>To test this premise we replaced each of the 15 proline residues of Cma individually with alanine. </plain></SENT>
<SENT sid="7718" pm="."><plain>The activities of the Cma mutant proteins encoded on pMLD237 were first tested with crude extracts of the <italic>E. coli</italic> pMLD237 transformant BL21(DE3) <italic>fkpA</italic> after IPTG induction of <italic>cma</italic> transcription. </plain></SENT>
<SENT sid="7719" pm="."><plain>The <italic>fkpA</italic> mutation prevented the producer cells to be killed by Cma. </plain></SENT>
<SENT sid="7720" pm="."><plain>In the crude extracts the mutant Cma was the dominant protein (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M110.165274/DC1">supplemental Fig. S1</ext-link>). </plain></SENT>
<SENT sid="7721" pm="."><plain>10-Fold dilutions of each mutant Cma protein sample were spotted on nutrient agar seeded with Cma-sensitive <italic>E. coli</italic> AB2847. </plain></SENT>
<SENT sid="7722" pm="."><plain>Four mutants (Cma(P9A), Cma(P11A), Cma(P28A), and Cma(P157A)) showed higher activities than wild-type Cma, and seven mutants had activities similar to that of the wild type (<xref ref-type="table" rid="T2">Table 2</xref>); these mutants were not studied further. </plain></SENT>
<SENT sid="7723" pm="."><plain>Cma(P129A), Cma(P176A), and Cma(P260A) displayed 1% of the wild-type activity, and Cma(P107A) showed 10% of the wild-type activity (<xref ref-type="table" rid="T2">Table 2</xref>). </plain></SENT>
<SENT sid="7724" pm="."><plain>Samples of the Cma(P → A) double mutants Cma(P129A,P176A), Cma(P129A,P260A), and Cma(P176A,P260A) were completely inactive (data not shown). </plain></SENT>
<SENT sid="7725" pm="."><plain>The location of the P107A, P129A, P176A, and P260A mutations in the Cma crystal structure is shown in <xref ref-type="fig" rid="F1">Fig. 1</xref>. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="T2" position="float"><label>TABLE 2</label><caption><p><text><SENT sid="7726" pm="."><plain><bold>Activities of the Cma Pro → Ala mutants</bold> </plain></SENT>
</text></p><p><text><SENT sid="7727" pm="."><plain>Clear zones of growth inhibition are listed. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead valign="bottom"><tr><th align="center" rowspan="2" colspan="1"><text><SENT sid="7728" pm="."><plain>Cma </plain></SENT>
</text></th><th align="center" colspan="4" rowspan="1"><text><SENT sid="7729" pm="."><plain>Diameter of the lysis zones<hr/> </plain></SENT>
</text></th></tr><tr><th align="center" rowspan="1" colspan="1"><text><SENT sid="7730" pm="."><plain>10<sup>0</sup> dilution </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="7731" pm="."><plain>10<sup>1</sup> dilution </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="7732" pm="."><plain>10<sup>2</sup> dilution </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="7733" pm="."><plain>10<sup>3</sup> dilution </plain></SENT>
</text></th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1"/><td align="center" colspan="4" rowspan="1"><text><SENT sid="7734" pm="."><plain><italic>mm</italic> </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7735" pm="."><plain>Wild-type </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7736" pm="."><plain>15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7737" pm="."><plain>11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7738" pm="."><plain>8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7739" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7740" pm="."><plain>P9A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7741" pm="."><plain>14 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7742" pm="."><plain>11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7743" pm="."><plain>9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7744" pm="."><plain>8 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7745" pm="."><plain>P11A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7746" pm="."><plain>15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7747" pm="."><plain>13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7748" pm="."><plain>10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7749" pm="."><plain>9 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7750" pm="."><plain>P16A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7751" pm="."><plain>14 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7752" pm="."><plain>11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7753" pm="."><plain>9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7754" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7755" pm="."><plain>P28A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7756" pm="."><plain>13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7757" pm="."><plain>10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7758" pm="."><plain>8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7759" pm="."><plain>6 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7760" pm="."><plain>P31A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7761" pm="."><plain>12 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7762" pm="."><plain>10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7763" pm="."><plain>8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7764" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7765" pm="."><plain>P35A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7766" pm="."><plain>13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7767" pm="."><plain>11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7768" pm="."><plain>8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7769" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7770" pm="."><plain>P48A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7771" pm="."><plain>15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7772" pm="."><plain>11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7773" pm="."><plain>8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7774" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7775" pm="."><plain>P70A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7776" pm="."><plain>13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7777" pm="."><plain>10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7778" pm="."><plain>7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7779" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7780" pm="."><plain>P94A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7781" pm="."><plain>12 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7782" pm="."><plain>10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7783" pm="."><plain>8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7784" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7785" pm="."><plain>P107A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7786" pm="."><plain>13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7787" pm="."><plain>11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7788" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7789" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7790" pm="."><plain>P109A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7791" pm="."><plain>13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7792" pm="."><plain>10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7793" pm="."><plain>8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7794" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7795" pm="."><plain>P129A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7796" pm="."><plain>10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7797" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7798" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7799" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7800" pm="."><plain>P157A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7801" pm="."><plain>15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7802" pm="."><plain>12 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7803" pm="."><plain>10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7804" pm="."><plain>8 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7805" pm="."><plain>P176A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7806" pm="."><plain>10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7807" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7808" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7809" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7810" pm="."><plain>P260A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7811" pm="."><plain>10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7812" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7813" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7814" pm="."><plain>0 </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag><SecTag type="FIG"><fig id="F1" position="float"><label>FIGURE 1.</label><caption><p><text><SENT sid="7815" pm="."><plain><bold>Location of the mutations in the crystal structure of Cma studied here (<xref ref-type="bibr" rid="B8">8</xref>).</bold> The predicted structural and functional domains are indicated; <italic>orange</italic>, N-terminal translocation domain; <italic>blue</italic>, central receptor binding domain; <italic>magenta</italic>, C-terminal activity domain; side chains of Pro-107, Pro-129, Pro-176, Pro-260, and Asp-226, which were replaced by alanine in this study are marked <italic>green</italic> (C-atoms, <italic>blue</italic> (nitrogen), and <italic>red</italic> (oxygen). </plain></SENT>
</text></p></caption><graphic xlink:href="zbc0111151010001"/></fig></SecTag><p><text><SENT sid="7816" pm="."><plain>To examine whether overproduction of FkpA increases the toxicity of the Cma(P → A) mutants, crude extracts of wild-type and the three Cma mutant proteins with the lowest activity were spotted onto nutrient agar plates seeded with <italic>E. coli</italic> AB2847 carrying in addition to chromosomal <italic>fkpA</italic>, also <italic>fkpA</italic> encoded on plasmid pYH15 and the temperature-inducible T7 RNA polymerase gene on plasmid pGP1-2. </plain></SENT>
<SENT sid="7817" pm="."><plain>The toxicity of each Cma protein for the FkpA-overproducing strain and for untransformed strain AB2847 was the same (data not shown), <italic>i.e.</italic> the amount of chromosomally encoded FkpA was sufficient to confer the respective sensitivity to Cma and its mutant derivatives. </plain></SENT>
</text></p><p><text><SENT sid="7818" pm="."><plain>Replacement of Pro-129, Pro-176, and Pro-260 by glycine or serine instead of alanine resulted in mutants with activities similar to those of the P → A mutants (data not shown). </plain></SENT>
<SENT sid="7819" pm="."><plain>The higher flexibility of the glycine bonds did not facilitate restoration of the active Cma conformation after transfer across the outer membrane, and the similarity of serine in the hydrogen-bonded form to proline did not increase Cma activity provided the proline residues were essential for Cma phosphatase activity (see also “Discussion”). </plain></SENT>
<SENT sid="7820" pm="."><plain>In addition, Pro-176 was replaced by leucine, valine, tyrosine, phenylalanine, lysine, and aspartate. </plain></SENT>
<SENT sid="7821" pm="."><plain>The Cma derivatives showed 1% <italic>in vivo</italic> activity on FkpA wild-type cells, except P176F and P176Y, which displayed 10% of Cma wild-type activity. </plain></SENT>
<SENT sid="7822" pm="."><plain>The activity of all mutant Cma proteins was zero on FkpA mutant cells. </plain></SENT>
</text></p><p><text><SENT sid="7823" pm="."><plain>FkpA is not required to produce an active Cma. </plain></SENT>
<SENT sid="7824" pm="."><plain>The activity of wild-type Cma released into the medium or isolated from the cytoplasm is the same when it is produced in wild-type and <italic>fkpA</italic> mutant cells (<xref ref-type="bibr" rid="B11">11</xref>). </plain></SENT>
<SENT sid="7825" pm="."><plain>FkpA is only required after uptake of Cma into the periplasm. </plain></SENT>
<SENT sid="7826" pm="."><plain>Nevertheless, we examined whether the low activity of the four Cma P → A mutants was altered when they were produced in <italic>E. coli</italic> BL21 FkpA<sup>+</sup> cells carrying a <italic>fhuA</italic> mutation, which confers resistance to Cma. </plain></SENT>
<SENT sid="7827" pm="."><plain>Killing <italic>E. coli</italic> AB2847 by the Cma mutant proteins synthesized in <italic>E. coli</italic> BL21 <italic>fhuA</italic> was the same (1 and 10% activity) as killing by the Cma mutant proteins synthesized in parallel by <italic>E. coli</italic> BL21 <italic>fkpA</italic>, <italic>i.e.</italic> lack of FkpA did not affect the activity of the Cma mutant proteins. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="7828" pm="."><plain>Structural Properties of the Cma P → A Mutant Proteins/Crystal Structures of Cma(P107A) and Cma(P176A) </plain></SENT>
</text></title><p><text><SENT sid="7829" pm="."><plain>Because the reduction in toxicity of the four mutant proteins might be related to changes in the structures, we determined the crystal structures of Cma(P107A) and Cma(P176A). </plain></SENT>
<SENT sid="7830" pm="."><plain>We selected these two proteins because Pro-107 forms the only proline <italic>cis</italic> bond in the Cma structure (<xref ref-type="bibr" rid="B8">8</xref>), and as will be shown below, the Pro-176 bond is most likely a target of FkpA. </plain></SENT>
<SENT sid="7831" pm="."><plain>Cma, Cma(P107A), and Cma(P176A) were expressed; the production of similar amounts of the almost inactive Cma derivatives and wild-type Cma indicated that replacement of the proline residues by alanine did not cause gross structural changes that affected the yield and activity of the proteins. </plain></SENT>
<SENT sid="7832" pm="."><plain>We determined an improved structure of wild-type Cma under conditions slightly different from those previously used (<xref ref-type="bibr" rid="B8">8</xref>) to 1.67 Å (<xref ref-type="fig" rid="F2">Fig. 2</xref><italic>A</italic>). </plain></SENT>
<SENT sid="7833" pm="."><plain>The published structures of Cma (Ref. <xref ref-type="bibr" rid="B8">8</xref>; PDB entries <ext-link ext-link-type="pdb" xlink:href="3DA4">3DA4</ext-link> and <ext-link ext-link-type="pdb" xlink:href="3DA3">3DA3</ext-link>) showed partial disorder, in particular in the flexible N-terminal domain, which is frequently not seen in colicin structures. </plain></SENT>
<SENT sid="7834" pm="."><plain>The new wild-type structure, in contrast, showed an excellent defined structural homogeneity for all main and side-chain atoms (<xref ref-type="fig" rid="F2">Fig. 2</xref><italic>A</italic>). </plain></SENT>
<SENT sid="7835" pm="."><plain>We determined the crystal structures of mutants Cma(P107A) and Cma(P176A) to 2.3 Å (eight monomers in the asymmetric unit) and 2.15 Å (two monomers in the asymmetric unit), respectively. </plain></SENT>
<SENT sid="7836" pm="."><plain>Crystallographic data are summarized in <xref ref-type="table" rid="T3">Table 3</xref>. </plain></SENT>
<SENT sid="7837" pm="."><plain>The root mean square deviation between the mutant (P107A and P176A) and the wild-type structures was 0.3 and 0.2 Å<sup>2</sup>, respectively, including all Cα-atoms of the molecule. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F2" position="float"><label>FIGURE 2.</label><caption><p><text><SENT sid="7838" pm="."><plain><italic>A</italic>, ribbon model representation of the newly determined Cma wt structure in a side view illustration (PDB <ext-link ext-link-type="pdb" xlink:href="2XMX">2XMX</ext-link>) is shown. </plain></SENT>
<SENT sid="7839" pm="."><plain>The structure consists of three domains, the N-terminal translocation domain (in <italic>green</italic>; <italic>T</italic>), the intermediate receptor binding domain (<italic>blue</italic>; <italic>R</italic>), and the C-terminal activity domains (<italic>orange</italic>; <italic>R</italic>). </plain></SENT>
<SENT sid="7840" pm="."><plain>The secondary structure elements and N (<italic>NT</italic>) and C termini (<italic>CT</italic>) of the structure as well as the two residues mutated are marked accordingly (α<italic>1</italic>-α<italic>5</italic>, β<italic>1</italic>-β<italic>6</italic>, <italic>NT</italic>, <italic>CT</italic>, <italic>P107</italic>, <italic>P176</italic>). <italic>B</italic>, superposition of the three structures represented as ribbon models (PDB <ext-link ext-link-type="pdb" xlink:href="2XTR">2XTR</ext-link>). </plain></SENT>
<SENT sid="7841" pm="."><plain>The wt structure is color-coded in <italic>orange</italic>, the P107A mutant structure is in <italic>blue</italic>, and the P176A structure is in <italic>red. </plain></SENT>
<SENT sid="7842" pm="."><plain>C</italic>, zoom into the region of the extended loop connecting the receptor binding and activity domain is shown. </plain></SENT>
<SENT sid="7843" pm="."><plain>Wt and mutant structures are displayed in the same orientation and color-coded as in <italic>B</italic>, and adjacent residues of the mutant (P107A) are shown in <italic>ball-and-stick</italic> representation. <italic>D</italic>, close-up of the second mutation Pro-176 located in the β1-sheet of the protein is shown. wt and mutant structures are displayed in the same orientation and color coded as in <italic>B</italic>; adjacent residues of the P176A mutant are shown in a <italic>ball-and-stick</italic> representation. </plain></SENT>
</text></p></caption><graphic xlink:href="zbc0111151010002"/></fig></SecTag><SecTag type="TABLE"><table-wrap id="T3" position="float"><label>TABLE 3</label><caption><p><text><SENT sid="7844" pm="."><plain><bold>Data collection and refinement statistics</bold> </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead valign="bottom"><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"><text><SENT sid="7845" pm="."><plain>Cma(WT) </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="7846" pm="."><plain>Cma(P107A) </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="7847" pm="."><plain>Cma(P176A) </plain></SENT>
</text></th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7848" pm="."><plain><bold>Data collection</bold> </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7849" pm="."><plain>    Space group </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7850" pm="."><plain>C222<sub>1</sub> </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7851" pm="."><plain>P1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7852" pm="."><plain>C222<sub>1</sub> </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7853" pm="."><plain>    Cell dimensions </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7854" pm="."><plain>        <italic>a</italic>, <italic>b</italic>, <italic>c</italic> (Å) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7855" pm="."><plain>52.75, 115.10, 227.71 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7856" pm="."><plain>52.85, 63.11, 189.34 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7857" pm="."><plain>52.83, 114.77, 225.40 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7858" pm="."><plain>        α, β, γ (°) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7859" pm="."><plain>90 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7860" pm="."><plain>87.59, 82.17, 65.65 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7861" pm="."><plain>90 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7862" pm="."><plain>    Resolution (Å) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7863" pm="."><plain>48-1.67<xref ref-type="table-fn" rid="TF3-1"><italic><sup>a</sup></italic></xref> (1.71-1.67) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7864" pm="."><plain>49-2.31 (2.37-2.30) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7865" pm="."><plain>47-2.14 (2.19-2.14) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7866" pm="."><plain>    <italic>R</italic><sub>sym</sub> or <italic>R</italic><sub>merge</sub> </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7867" pm="."><plain>0.08 (0.57) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7868" pm="."><plain>0.09 (0.40) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7869" pm="."><plain>0.19 (0.82) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7870" pm="."><plain>    <italic>I</italic>/σ<italic>I</italic> </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7871" pm="."><plain>14.2 (1.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7872" pm="."><plain>5.4 (1.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7873" pm="."><plain>9.2 (2.0) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7874" pm="."><plain>    Completeness (%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7875" pm="."><plain>97.3 (83.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7876" pm="."><plain>89.5 (72.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7877" pm="."><plain>99.0 (94.2) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7878" pm="."><plain>    Redundancy </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7879" pm="."><plain>5.2 (3.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7880" pm="."><plain>1.7 (1.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7881" pm="."><plain>6.3 (4.9) </plain></SENT>
</text></td></tr><tr><td colspan="4" rowspan="1"><text><SENT sid="7882" pm="."><plain><hr/> </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7883" pm="."><plain><bold>Refinement</bold> </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7884" pm="."><plain>    Resolution (Å) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7885" pm="."><plain>48-1.67 (1.71-1.67) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7886" pm="."><plain>49-2.31 (2.37-2.31) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7887" pm="."><plain>47-2.14 (2.19-2.14) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7888" pm="."><plain>    No. reflections </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7889" pm="."><plain>73413 (5526) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7890" pm="."><plain>85754 (4514) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7891" pm="."><plain>36063 (1898) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7892" pm="."><plain>    <italic>R</italic><sub>work</sub>/<italic>R</italic><sub>free</sub> </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7893" pm="."><plain>0.16/0.20 (0.25/0.30) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7894" pm="."><plain>0.24/0.27 (0.31/0.33) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7895" pm="."><plain>0.18/0.24 (0.26/0.30) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7896" pm="."><plain>    No. atoms (all) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7897" pm="."><plain>4,733 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7898" pm="."><plain>17,005 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7899" pm="."><plain>4,376 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7900" pm="."><plain>        Protein (chains/residues) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7901" pm="."><plain>2/540 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7902" pm="."><plain>8/2160 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7903" pm="."><plain>2/540 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7904" pm="."><plain>        Ligands (nitrate/glycerol) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7905" pm="."><plain>3/4 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="7906" pm="."><plain>1/0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7907" pm="."><plain>        Water </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7908" pm="."><plain>434 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7909" pm="."><plain>451 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7910" pm="."><plain>319 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7911" pm="."><plain>    <italic>B</italic>-Factors </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7912" pm="."><plain>        Protein </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7913" pm="."><plain>5.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7914" pm="."><plain>13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7915" pm="."><plain>20.6 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7916" pm="."><plain>        Ligands (nitrate/glycerol) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7917" pm="."><plain>20/23 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="7918" pm="."><plain>34/- </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7919" pm="."><plain>        Water </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7920" pm="."><plain>15.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7921" pm="."><plain>9.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7922" pm="."><plain>26.1 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7923" pm="."><plain>    Root mean square deviations </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7924" pm="."><plain>        Bond lengths (Å) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7925" pm="."><plain>0.027 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7926" pm="."><plain>0.016 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7927" pm="."><plain>0.023 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7928" pm="."><plain>        Bond angles (°) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7929" pm="."><plain>2.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7930" pm="."><plain>1.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7931" pm="."><plain>2.0 </plain></SENT>
</text></td></tr><tr><td colspan="4" rowspan="1"><text><SENT sid="7932" pm="."><plain><hr/> </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7933" pm="."><plain><bold>Ramachandran statistics</bold> </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7934" pm="."><plain>    Residues in favored regions (%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7935" pm="."><plain>532 (99.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7936" pm="."><plain>2123 (99) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7937" pm="."><plain>531 (99.1) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7938" pm="."><plain>    Residues in allowed region (%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7939" pm="."><plain>3 (0.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7940" pm="."><plain>21 (1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7941" pm="."><plain>5 (0.9) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7942" pm="."><plain>    Residues in outlier region (%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7943" pm="."><plain>1 (0.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7944" pm="."><plain>0 (0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7945" pm="."><plain>0 (0) </plain></SENT>
</text></td></tr><tr><td colspan="4" rowspan="1"><text><SENT sid="7946" pm="."><plain><hr/> </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7947" pm="."><plain><bold>Crystallization conditions</bold> </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7948" pm="."><plain>20% PEG 3350 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7949" pm="."><plain>20% PEG 3350 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7950" pm="."><plain>20% PEG 3350 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="7951" pm="."><plain>0.2 <sc>m</sc> NaNO<sub>3</sub> </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7952" pm="."><plain>0.2 <sc>m</sc> NaNO<sub>3</sub>, 0.1 <sc>m</sc> Bis/Tris, pH 6.5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7953" pm="."><plain>0.2 <sc>m</sc> NaNO<sub>3</sub> </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7954" pm="."><plain>    Cryo protectant added </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7955" pm="."><plain>10% PEG 400 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7956" pm="."><plain>10% PEG 400 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7957" pm="."><plain>10% PEG 400 </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn id="TF3-1"><p><text><SENT sid="7958" pm="."><plain><italic><sup>a</sup></italic> Values in parentheses are for highest-resolution shell. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="7959" pm="."><plain>Superposition of the Cma wild-type and mutant protein structures revealed identical folding (<xref ref-type="fig" rid="F2">Fig. 2</xref><italic>B</italic>). </plain></SENT>
<SENT sid="7960" pm="."><plain>Analysis of the local environment of each mutation revealed that the Lys-Pro <italic>cis</italic> bond in wild-type Cma was converted to a Lys-Ala <italic>trans</italic> bond in Cma(P107A), which caused a local distortion of the loop region that connects the receptor binding and the activity domains (<xref ref-type="fig" rid="F2">Fig. 2</xref><italic>C</italic>). </plain></SENT>
<SENT sid="7961" pm="."><plain>The structural changes were confined to the region around Pro-107 and elicited no long range structural transitions up to the predicted active center around Asp-226 (<xref ref-type="fig" rid="F1">Fig. 1</xref>) (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B29">29</xref>). </plain></SENT>
<SENT sid="7962" pm="."><plain>In contrast, the P176A mutation had no visible effect on the local backbone geometry of the β3 strand of Cma, as demonstrated in a section of Cma(P176A) overlaid by wild-type Cma (<xref ref-type="fig" rid="F2">Fig. 2</xref><italic>D</italic>). </plain></SENT>
<SENT sid="7963" pm="."><plain>The entire structures were almost identical, which indicates that no conformational change inactivated Cma(P176A). </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="7964" pm="."><plain>Structural Properties of the Cma P → A Mutant Proteins in Solution </plain></SENT>
</text></title><p><text><SENT sid="7965" pm="."><plain>Although the crystal structure of Cma(P176A) and most likely also of Cma(P107A) excluded structural alterations of the Cma activity domain as the cause of the low toxicity, we examined the structures of the three mutants with 1% wild-type activity in solution using proteinase K degradation, circular dichroism (CD), and tryptophan fluorescence spectroscopy after denaturation with urea. </plain></SENT>
<SENT sid="7966" pm="."><plain>Cma(P107A) was not included in all assays because it displayed a Cma activity higher (10%) than that of the other mutant proteins (1%). </plain></SENT>
</text></p><p><text><SENT sid="7967" pm="."><plain>We chose proteinase K cleavage conditions such that Cma was not completely digested; instead, fragments were formed, of which the 24-kDa fragment resulted from Cma truncation at the N terminus (<xref ref-type="bibr" rid="B7">7</xref>). </plain></SENT>
<SENT sid="7968" pm="."><plain>By analyzing the formation of this intermediary product instead of analyzing complete digestion, differences in the structure of Cma and its mutant forms should become more apparent. </plain></SENT>
<SENT sid="7969" pm="."><plain>No differences in the cleavage pattern of wild-type Cma and the Cma mutants were observed (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M110.165274/DC1">supplemental Fig. S2</ext-link>). </plain></SENT>
</text></p><p><text><SENT sid="7970" pm="."><plain>Next, we used CD spectroscopy to discern whether the mutant Cma proteins structurally differed from wild-type Cma. </plain></SENT>
<SENT sid="7971" pm="."><plain>The far-UV CD spectra of the four Cma mutants and the Cma wild-type were the same at 20 °C (data not shown). </plain></SENT>
<SENT sid="7972" pm="."><plain>However, at higher temperatures, the CD spectra indicated that Cma(P107A) (<italic>T<sub>m</sub></italic> = 51.8 °C) and Cma(P129A) (<italic>T<sub>m</sub></italic> = 48.8 °C) denatured at a lower temperature than Cma (<italic>T<sub>m</sub></italic> = 55.8 °C), Cma(P176A) (<italic>T<sub>m</sub></italic> = 55.4 °C), and Cma(P260A) (<italic>T<sub>m</sub></italic> = 55.0 °C) (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M110.165274/DC1">supplemental Fig. S3</ext-link>). </plain></SENT>
</text></p><p><text><SENT sid="7973" pm="."><plain>We furthermore examined structural changes in the mutant proteins by measuring the fluorescence of urea-denatured proteins. </plain></SENT>
<SENT sid="7974" pm="."><plain>The fluorescence emission maximum shifted to the red from 320 to 355 nm for Cma(P107A) and Cma(P129A) between 4 and 5 <sc>m</sc> urea and for Cma(P176A), Cma(P260A), and wild-type Cma between 5 and 6 <sc>m</sc> urea (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M110.165274/DC1">supplemental Fig. S4</ext-link>). </plain></SENT>
<SENT sid="7975" pm="."><plain>The lower urea stability of Cma(P107A) and Cma(P129A) agrees with their lower stability at higher temperatures. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="7976" pm="."><plain>Translocation of the Cma P → A Mutant Proteins Across the Outer Membrane </plain></SENT>
</text></title><p><text><SENT sid="7977" pm="."><plain>We examined whether the <italic>Cma</italic> P → A mutants were defective in binding to the FhuA receptor and in translocation across the outer membrane. </plain></SENT>
<SENT sid="7978" pm="."><plain>Receptor binding was determined by competition of Cma with the antibiotic albomycin, which binds to the same FhuA receptor as Cma. <italic>E. coli</italic> Mo3 <italic>fkpA40</italic> was used because the <italic>fkpA</italic> deletion confers resistance to Cma (<xref ref-type="bibr" rid="B11">11</xref>). </plain></SENT>
<SENT sid="7979" pm="."><plain>Growth inhibition was, therefore, confined to the action of albomycin. </plain></SENT>
<SENT sid="7980" pm="."><plain>Albomycin inhibited growth of <italic>E. coli</italic> Mo3 (<xref ref-type="fig" rid="F3">Fig. 3</xref>). </plain></SENT>
<SENT sid="7981" pm="."><plain>Wild-type Cma prevented growth inhibition by albomycin, as did Cma(P107A), Cma(P176A), and Cma(P260A). </plain></SENT>
<SENT sid="7982" pm="."><plain>These proteins probably interfered with binding of albomycin to FhuA. </plain></SENT>
<SENT sid="7983" pm="."><plain>In contrast, Cma(P129A) failed to interfere with albomycin. </plain></SENT>
<SENT sid="7984" pm="."><plain>The low activity of Cma(P129A), therefore, most likely results from poor binding to FhuA. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F3" position="float"><label>FIGURE 3.</label><caption><p><text><SENT sid="7985" pm="."><plain><bold>Binding of wild-type and mutant Cma proteins to the FhuA receptor in a competition assay with albomycin.</bold> Exponentially growing <italic>E. coli</italic> Mo3 <italic>fkpA40</italic> in LB medium untreated (■) and treated with 1 μg ml<sup>−1</sup> albomycin (▴), treated with 0.1 mg ml<sup>−1</sup> wild-type Cma and albomycin (□), with mutant Cma(P107A) and albomycin (♢), with mutant Cma(P129A) and albomycin (●), with mutant Cma(P176A) and albomycin (○), and with mutant Cma(P260A) and albomycin (▵). </plain></SENT>
<SENT sid="7986" pm="."><plain>Growth was monitored spectrophotometrically. </plain></SENT>
<SENT sid="7987" pm="."><plain>The <italic>arrows</italic> indicate the addition of the Cma samples and albomycin. </plain></SENT>
</text></p></caption><graphic xlink:href="zbc0111151010003"/></fig></SecTag><p><text><SENT sid="7988" pm="."><plain>Cma and albomycin not only share the common FhuA receptor, but also both use the Ton system for uptake. </plain></SENT>
<SENT sid="7989" pm="."><plain>It is unlikely that albomycin uptake was inhibited because uptake of Cma, and its derivatives used up TonB. </plain></SENT>
<SENT sid="7990" pm="."><plain>TonB can simultaneously interact with several receptors without substantially decreasing their transport rate (<xref ref-type="bibr" rid="B30">30</xref>). </plain></SENT>
<SENT sid="7991" pm="."><plain>Reduction of the transport rate of a substrate was only observed after strong overexpression of another TonB-dependent transport system (<xref ref-type="bibr" rid="B30">30</xref>). </plain></SENT>
<SENT sid="7992" pm="."><plain>Nevertheless, we determined whether Cma(P176A) and Cma(P260A) interfered with the activity of the Ton system. </plain></SENT>
<SENT sid="7993" pm="."><plain>The competition assay was done with colicin B instead of albomycin; colicin B binds to the FepA receptor and not to FhuA but uses the Ton system for uptake. </plain></SENT>
<SENT sid="7994" pm="."><plain>The <italic>Cma</italic> P → A mutants did not reduce growth inhibition of the Cma-resistant <italic>fkpA</italic> mutant Mo3 by colicin B, which indicates that the Cma mutant proteins do not interfere with the Ton system step of albomycin uptake. </plain></SENT>
<SENT sid="7995" pm="."><plain>Interference of Cma with the target site of albomycin is also excluded as albomycin inhibits the seryl-tRNA synthetase; Cma, on the other hand, cleaves the phosphate ester bond between bactoprenol and the murein precursor. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="7996" pm="."><plain>Lack of Translocation Versus Lack of Phosphatase Activity </plain></SENT>
</text></title><p><text><SENT sid="7997" pm="."><plain>To differentiate between lack of translocation across the outer membrane and lack of phosphatase activity, we used an osmotic shock procedure. </plain></SENT>
<SENT sid="7998" pm="."><plain>Transferring <italic>E. coli</italic> cells from a medium of high osmolarity to a medium of low osmolarity renders their outer membrane temporarily permeable to proteins. </plain></SENT>
<SENT sid="7999" pm="."><plain>The procedure was developed and widely used to release periplasmic proteins from cells (<xref ref-type="bibr" rid="B27">27</xref>) but can also be used to introduce proteins into cells, as has been shown for colicin E3 (<xref ref-type="bibr" rid="B28">28</xref>) and Cma (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B29">29</xref>). </plain></SENT>
<SENT sid="8000" pm="."><plain>The uptake of Cma by osmotic shock bypasses the requirement for the FhuA outer membrane receptor protein and the energizing Ton system. </plain></SENT>
<SENT sid="8001" pm="."><plain>A variation of this procedure (<xref ref-type="bibr" rid="B10">10</xref>) was recently used to differentiate between Cma uptake and activity mutants (<xref ref-type="bibr" rid="B9">9</xref>). </plain></SENT>
<SENT sid="8002" pm="."><plain>We purified wild-type and mutant proteins to electrophoretic homogeneity (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M110.165274/DC1">supplemental Fig. S2</ext-link>) and used the same amounts of protein in the osmotic shock experiments. </plain></SENT>
<SENT sid="8003" pm="."><plain>Osmotic shock treatment rendered cells sensitive to Cma(P107A), Cma(P129A), and Cma(P260A) (0.03 or 0.04% survivors) and to Cma(P176A) but to a much lower extent (0.4% survivors) (<xref ref-type="table" rid="T4">Table 4</xref>). </plain></SENT>
<SENT sid="8004" pm="."><plain>Killing by Cma(P129A) after osmotic shock agrees with its inability to kill cells under normal conditions because of its failure to bind to FhuA, which is not required to enter osmotically shocked cells. </plain></SENT>
<SENT sid="8005" pm="."><plain>Because Cma(P107A) and Cma(P260A) bound to FhuA but hardly killed cells under normal conditions and were able to kill osmotically shocked cells after being unspecifically translocated into the periplasm, the uptake of these mutant proteins across the outer membrane must be impaired after binding to FhuA. </plain></SENT>
<SENT sid="8006" pm="."><plain>We conclude that Cma(P107A), Cma(P129A), and Cma(P260A) show low activities because they are poorly taken up into the periplasm. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="T4" position="float"><label>TABLE 4</label><caption><p><text><SENT sid="8007" pm="."><plain><bold>Activity of selected Cma mutant proteins introduced into cells by osmotic shock</bold> </plain></SENT>
</text></p><p><text><SENT sid="8008" pm="."><plain>The percent of surviving cells of AB2847, its <italic>fkpA40</italic> derivative, and the pPG773 <italic>cmi</italic> transformant were determined by plating after treatment with purified Cma wt and Cma mutant proteins transferred into cells by osmotic shock (+ shock) or without shock treatment (− shock). </plain></SENT>
<SENT sid="8009" pm="."><plain>The average percentage of survivors of all experiments after shock treatment without Cma was 6.0. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead valign="bottom"><tr><th align="center" rowspan="2" colspan="1"><text><SENT sid="8010" pm="."><plain>Conditions </plain></SENT>
</text></th><th align="center" colspan="3" rowspan="1"><text><SENT sid="8011" pm="."><plain>Surviving cells<hr/> </plain></SENT>
</text></th></tr><tr><th align="center" rowspan="1" colspan="1"><text><SENT sid="8012" pm="."><plain>AB2847 </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="8013" pm="."><plain>AB2847 <italic>fkpA</italic> </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="8014" pm="."><plain>AB2847 pPG773 <italic>cmi</italic> </plain></SENT>
</text></th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1"/><td align="center" colspan="3" rowspan="1"><text><SENT sid="8015" pm="."><plain><italic>Percent of input</italic> </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="8016" pm="."><plain>Cma wt + shock </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8017" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8018" pm="."><plain>1.5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8019" pm="."><plain>6.1 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="8020" pm="."><plain>Cma wt − shock </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8021" pm="."><plain>0.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8022" pm="."><plain>93.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8023" pm="."><plain>97.4 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="8024" pm="."><plain>Cma(P107A) + shock </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8025" pm="."><plain>0.03 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8026" pm="."><plain>1.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8027" pm="."><plain>8.8 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="8028" pm="."><plain>Cma(P107A) − shock </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8029" pm="."><plain>1.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8030" pm="."><plain>91.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8031" pm="."><plain>93.9 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="8032" pm="."><plain>Cma(P129A) + shock </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8033" pm="."><plain>0.04 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8034" pm="."><plain>0.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8035" pm="."><plain>7.0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="8036" pm="."><plain>Cma(P129A) − shock </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8037" pm="."><plain>1.9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8038" pm="."><plain>95.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8039" pm="."><plain>95.8 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="8040" pm="."><plain>Cma(P176A) + shock </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8041" pm="."><plain>0.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8042" pm="."><plain>0.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8043" pm="."><plain>8.9 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="8044" pm="."><plain>Cma(P176A) − shock </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8045" pm="."><plain>9.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8046" pm="."><plain>90.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8047" pm="."><plain>97.3 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="8048" pm="."><plain>Cma(P260A) + shock </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8049" pm="."><plain>0.03 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8050" pm="."><plain>0.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8051" pm="."><plain>5.8 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="8052" pm="."><plain>Cma(P260A) − shock </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8053" pm="."><plain>1.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8054" pm="."><plain>90.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8055" pm="."><plain>100 </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag><p><text><SENT sid="8056" pm="."><plain>Wild-type and mutant Cma proteins were osmotically shocked into an <italic>fkpA</italic> deletion mutant to test whether FkpA was only required for the energy-coupled transfer of Cma across the outer membrane or also required after unspecific transfer by osmotic shock. </plain></SENT>
<SENT sid="8057" pm="."><plain>The Cma proteins were osmotically shocked into <italic>E. coli</italic> Mo3 <italic>fkpA40</italic> under conditions identical to those for the <italic>fkpA</italic> wild-type strain. </plain></SENT>
<SENT sid="8058" pm="."><plain>Killing of the <italic>fkpA</italic> mutant by wild-type Cma and the proline Cma mutant proteins was strongly reduced (<xref ref-type="table" rid="T4">Table 4</xref>), which shows that regardless of the route across the outer membrane (energy-coupled import or entry by osmotic shock) FkpA was required for wild-type and mutant Cma activity in the periplasm. </plain></SENT>
<SENT sid="8059" pm="."><plain>The results also demonstrated the reliability of the osmotic shock procedure as the Cma activities specifically required FkpA. </plain></SENT>
<SENT sid="8060" pm="."><plain>However, the Cma proteins displayed residual Cma activities; 0.2–1.8% survival compared with 6% survival after osmotic shock in the absence of the Cma proteins (<xref ref-type="table" rid="T4">Table 4</xref>). </plain></SENT>
<SENT sid="8061" pm="."><plain>After osmotic shock, a fraction of the Cma molecules was active in the absence of FkpA. </plain></SENT>
</text></p><p><text><SENT sid="8062" pm="."><plain>This conclusion was further supported by comparison of the surviving <italic>fkpA</italic> mutant cells with cells that synthesize the Cmi colicin M immunity protein. </plain></SENT>
<SENT sid="8063" pm="."><plain>Cmi renders cells resistant to imported Cma (<xref ref-type="bibr" rid="B31">31</xref>). </plain></SENT>
<SENT sid="8064" pm="."><plain>Cmi is located in the periplasm and anchored to the cytoplasmic membrane by its N-terminal hydrophobic sequence (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>). </plain></SENT>
<SENT sid="8065" pm="."><plain>Membrane fixation brings Cmi to the site where Cma cleaves its substrate and prevents release of Cmi by osmotic shock. </plain></SENT>
<SENT sid="8066" pm="."><plain>We used the previously constructed plasmid pPG773, in which the translocation and membrane anchor of the penicillin-binding protein PBP3 was fused to the periplasmic activity domain of Cmi (<xref ref-type="bibr" rid="B33">33</xref>). </plain></SENT>
<SENT sid="8067" pm="."><plain>Transformants carrying this plasmid confer immunity without induction of T7 polymerase synthesis because it contains an <italic>E. coli</italic> polymerase promoter. </plain></SENT>
<SENT sid="8068" pm="."><plain>Wild-type Cma and the Cma P → A mutant proteins were completely inactive on plates seeded with <italic>E. coli</italic> AB2847 pPG773 <italic>cmi</italic>. </plain></SENT>
<SENT sid="8069" pm="."><plain>After osmotic shock, Cma and the Cma derivatives were inactive (<xref ref-type="table" rid="T4">Table 4</xref>). </plain></SENT>
<SENT sid="8070" pm="."><plain>The percentage of survivors (average 7%) was in the range of the survivors after osmotic shock treatment without Cma (6%). </plain></SENT>
<SENT sid="8071" pm="."><plain>This shows that the Cma proteins that entered cells by osmotic shock were completely inactivated by Cmi. </plain></SENT>
<SENT sid="8072" pm="."><plain>The fraction of surviving cells into which Cma and the Cma derivatives entered via the normal, energy-coupled route was similar in the <italic>fkpA</italic> mutant and the <italic>cmi</italic> transformants (92 and 100%, respectively; <xref ref-type="table" rid="T4">Table 4</xref>). </plain></SENT>
<SENT sid="8073" pm="."><plain>The almost complete resistance of the <italic>fkpA</italic> mutant to Cma and its mutant derivatives that enter the cell by energy-coupled uptake (− shock in <xref ref-type="table" rid="T4">Table 4</xref>) and the partial sensitivity of the <italic>fkpA</italic> mutant when Cma and its mutant derivatives are osmotically shocked into the cell support the conclusion that a fraction of Cma osmotically shocked into cells is active in the absence of FkpA. </plain></SENT>
<SENT sid="8074" pm="."><plain>This fraction assumes an active conformation without the assistance of FkpA. </plain></SENT>
</text></p><p><text><SENT sid="8075" pm="."><plain>Cma(P176A) differed from the other Cma P → A mutants in that its low activity after osmotic shock did not differ in wild-type and <italic>fkpA</italic> cells (0.4 <italic>versus</italic> 0.6% survivors). </plain></SENT>
<SENT sid="8076" pm="."><plain>The percentage of survivors of the immune cells treated with Cma(P176A) reached the level obtained with wild-type Cma and the other Cma P → A mutant proteins (<xref ref-type="table" rid="T4">Table 4</xref>). </plain></SENT>
<SENT sid="8077" pm="."><plain>This suggests that the residual activity of Cma(P176A) in Cmi-deficient cells is Cma-specific. </plain></SENT>
</text></p><p><text><SENT sid="8078" pm="."><plain>The number of survivors in the control of the osmotic shock procedure, <italic>i.e.</italic> without osmotic shock treatment (<xref ref-type="table" rid="T4">Table 4</xref>), cannot be quantitatively compared with the number of survivors obtained by the plate test (<xref ref-type="table" rid="T2">Table 2</xref>). </plain></SENT>
<SENT sid="8079" pm="."><plain>In the osmotic shock procedure, test cells are exposed to Cma for 15 min at 4 °C, diluted, and then plated; in the plate test, cells are exposed to Cma overnight at 37 °C. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="8080" pm="."><plain>Killing of Cells by Secreted Wild-type and Cma P → A Mutants </plain></SENT>
</text></title><p><text><SENT sid="8081" pm="."><plain>Colicins, including Cma, are not secreted but are rather unspecifically released by partial lysis of the producing cells. </plain></SENT>
<SENT sid="8082" pm="."><plain>Lysis is caused by a lysis protein that is not encoded on pColBM plasmids (<xref ref-type="bibr" rid="B26">26</xref>). </plain></SENT>
<SENT sid="8083" pm="."><plain>Therefore, 90% of the Cma stays inside cells. </plain></SENT>
<SENT sid="8084" pm="."><plain>To examine whether Cma translocated across the outer membrane only requires FkpA or whether Cma secreted across the cytoplasmic membrane also requires FkpA, we fused wild-type and mutant Cma proteins to the signal sequence of the periplasmic MalE-binding protein. </plain></SENT>
<SENT sid="8085" pm="."><plain>In a previous paper of our laboratory (<xref ref-type="bibr" rid="B34">34</xref>) Cma was fused to the signal peptide of the murein lipoprotein and killed cells of <italic>fhuA</italic>, <italic>tonB</italic>, and <italic>exbBD</italic> uptake mutants but left a <italic>tolM</italic>, now designated <italic>fkpA</italic>, mutant unaffected. </plain></SENT>
<SENT sid="8086" pm="."><plain>The Cma constructs chosen in this paper contained the MalE signal peptide for secretion and C-terminal His<sub>6</sub> for purification and are designated as secreted Cma (Cma<sub>sec</sub>). </plain></SENT>
<SENT sid="8087" pm="."><plain>We cloned the fusion gene downstream of the <italic>araC</italic> arabinose promoter, which tightly controls transcription of downstream genes. </plain></SENT>
<SENT sid="8088" pm="."><plain>This was important for cloning as uninduced transcription might have resulted in cell lysis and failure to obtain transformants. </plain></SENT>
<SENT sid="8089" pm="."><plain>In addition, the level of expression can be modulated over a wide range (up to 1200-fold) depending on the concentration of the arabinose inducer (<xref ref-type="bibr" rid="B35">35</xref>). </plain></SENT>
<SENT sid="8090" pm="."><plain>Cma<sub>sec</sub> transformants grew well in the uninduced state and stopped growing upon induction of <italic>cma<sub>sec</sub></italic> transcription with 0.1% arabinose. </plain></SENT>
<SENT sid="8091" pm="."><plain>Growth inhibition could be caused by the phosphatase activity of Cma or by Cma jamming the secretion pathway by folding in the cytoplasm before secretion, as has for example been shown for the outer membrane LamB protein fused to a large C-terminal fragment of β-galactosidase. </plain></SENT>
<SENT sid="8092" pm="."><plain>In this case cells become sensitive to induction by maltose as enhanced synthesis of the LamB-LacZ hybrid protein impairs secretion of LamB-LacZ and of other proteins (<xref ref-type="bibr" rid="B36">36</xref>). </plain></SENT>
<SENT sid="8093" pm="."><plain>Indeed, 0.1% arabinose inhibited not only the growth of cells that synthesized wild-type Cma<sub>sec</sub> but also of cells that synthesized inactive mutant Cma<sub>sec</sub>(D226A) (data not shown). </plain></SENT>
<SENT sid="8094" pm="."><plain>Asp-226 is located in the predicted active center of Cma and is essential for Cma activity (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B29">29</xref>). </plain></SENT>
<SENT sid="8095" pm="."><plain>At an arabinose concentration of 0.001%, Cma(D226A) did not inhibit growth, but wild-type Cma and Cma(P107A), with 10% activity in the plate test, completely inhibited growth and lysed cells (<xref ref-type="fig" rid="F4">Fig. 4</xref><italic>A</italic>). </plain></SENT>
<SENT sid="8096" pm="."><plain>Cma(P129A), Cma(P176A), and Cma(P260A) displayed residual activities, with Cma(P176A) having the lowest. </plain></SENT>
<SENT sid="8097" pm="."><plain>To compare growth inhibition of wild-type with an <italic>fkpA</italic> mutant, we increased the level of the Cma mutant proteins by enhancing transcription with a higher arabinose concentration (0.01%). </plain></SENT>
<SENT sid="8098" pm="."><plain>At this concentration, Cma(D226A) failed to inhibit growth (<xref ref-type="fig" rid="F4">Fig. 4</xref><italic>B</italic>), which indicated that growth inhibition by interference with protein secretion played no role. </plain></SENT>
<SENT sid="8099" pm="."><plain>The Cma P → A mutant proteins now inhibited growth, which was abolished in the <italic>fkpA</italic> strain. </plain></SENT>
<SENT sid="8100" pm="."><plain>Regardless of whether Cma and its mutant derivatives were imported across the outer membrane or secreted across the cytoplasmic membrane, they required FkpA to be active in the periplasm. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F4" position="float"><label>FIGURE 4.</label><caption><p><text><SENT sid="8101" pm="."><plain><bold>Growth inhibition and lysis of <italic>E. coli</italic> Mo3 <italic>fkpA</italic> (<italic>filled symbols</italic>) and <italic>E. coli</italic> MB97 <italic>fhuA</italic> (<italic>open symbols</italic>) by Cma and its mutant derivatives fused to the MalE signal sequence after induction of Cma synthesis by 0.001% arabinose (<italic>A</italic>) and 0.01% arabinose (<italic>B</italic>).</bold> Samples were withdrawn at the indicated times, and the optical density (OD) was measured at 578 nm. </plain></SENT>
</text></p></caption><graphic xlink:href="zbc0111151010004"/></fig></SecTag></sec><sec><title><text><SENT sid="8102" pm="."><plain>Catalysis of Prolyl Cis-Trans Isomerization of the Phe-Pro-176 Bond by FkpA </plain></SENT>
</text></title><p><text><SENT sid="8103" pm="."><plain>Cma(P176A) shocked into the periplasm had a 10-fold lower activity than the other Cma P → A mutants. </plain></SENT>
<SENT sid="8104" pm="."><plain>This residual activity was independent of FkpA, which suggested that the replacement of Pro-176 by alanine affected interaction with FkpA. </plain></SENT>
<SENT sid="8105" pm="."><plain>The Phe-Ala-176 bond is not a substrate of FkpA since FkpA-type PPIases do not catalyze <italic>cis-trans</italic> isomerization of nonprolyl peptide bonds (<xref ref-type="bibr" rid="B37">37</xref>). </plain></SENT>
<SENT sid="8106" pm="."><plain>To test whether the Phe-Pro-176 bond serves as a substrate for the FkpA PPIase, we used a novel peptide assay. </plain></SENT>
<SENT sid="8107" pm="."><plain>Disulfide-constrained synthetic pentapeptide derivatives of the amino acid sequence <italic>p</italic>-aminobenzoyl-Cys-Xaa-Pro-Yaa-Cys-(NO<sub>2</sub>)Tyr-NH<sub>2</sub> exhibit a high content of Xaa-Pro <italic>cis</italic> conformation (<xref ref-type="bibr" rid="B38">38</xref>). </plain></SENT>
<SENT sid="8108" pm="."><plain>Upon opening of the disulfide bridge by reduction, the <italic>cis</italic>/<italic>trans</italic> ratio declines to an open-chain <italic>cis</italic> isomer level of ∼15% (<xref ref-type="bibr" rid="B39">39</xref>). </plain></SENT>
<SENT sid="8109" pm="."><plain>Only in the <italic>cis</italic> conformation is the fluorescence of the <italic>p</italic>-aminobenzoyl group efficiently quenched by the nitrotyrosine amide. </plain></SENT>
<SENT sid="8110" pm="."><plain>After reduction of the disulfide bridge, fluorescence increases during <italic>cis</italic>/<italic>trans</italic> interconversion of the Xaa-Pro bond. </plain></SENT>
<SENT sid="8111" pm="."><plain>This slow reaction is accelerated by PPIases, which use the peptides as substrates. </plain></SENT>
</text></p><p><text><SENT sid="8112" pm="."><plain>We compared spontaneous and FkpA-catalyzed <italic>cis-trans</italic> isomerization of the substrate <italic>p</italic>-aminobenzoyl-CFPVC-(NO<sub>2</sub>)Tyr-NH<sub>2</sub>, which represents the amino acid sequence adjacent to Cma Phe-Pro-176-Val, and used as controls <italic>p</italic>-aminobenzoyl-CKPAC-(NO<sub>2</sub>)Tyr-NH<sub>2</sub> and <italic>p</italic>-aminobenzoyl-CLPGC-(NO<sub>2</sub>)Tyr-NH<sub>2</sub>, which represent the amino acid sequences adjacent to Cma Lys-Pro-107-Ala and Cma Leu-Pro-260-Gly, respectively. </plain></SENT>
<SENT sid="8113" pm="."><plain>FkpA was purified to electrophoretic homogeneity by Ni-NTA-agarose chromatography and subsequent gel filtration on a Superdex 75 column. </plain></SENT>
<SENT sid="8114" pm="."><plain>FkpA considerably accelerated <italic>cis-trans</italic> isomerization of the prolyl bond in Phe-Pro-176-Val as compared with uncatalyzed spontaneous <italic>cis-trans</italic> isomerization (<xref ref-type="fig" rid="F5">Fig. 5</xref>). </plain></SENT>
<SENT sid="8115" pm="."><plain>The <italic>k</italic><sub>cat</sub>/<italic>K<sub>m</sub></italic> value of the catalyzed reaction was similar to the <italic>k</italic><sub>cat</sub>/<italic>K<sub>m</sub></italic> values of FKBP-type PPIases with optimal substrates (<xref ref-type="bibr" rid="B40">40</xref>). </plain></SENT>
<SENT sid="8116" pm="."><plain>The <italic>k</italic><sub>cat</sub>/<italic>K<sub>m</sub></italic> value was 14- and 12-fold more efficient than the <italic>k</italic><sub>cat</sub>/<italic>K<sub>m</sub></italic> values of the Lys-Pro-107-Ala and Leu-Pro-260-Gly peptides, respectively (<xref ref-type="fig" rid="F6">Fig. 6</xref>, <xref ref-type="table" rid="T5">Table 5</xref>). </plain></SENT>
<SENT sid="8117" pm="."><plain>The low value of the Lys-Pro-107-Ala peptide is particularly interesting because it indicates that the only <italic>cis</italic> prolyl bond in Cma is unlikely to be the site of FkpA <italic>cis-trans</italic> isomerization. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F5" position="float"><label>FIGURE 5.</label><caption><p><text><SENT sid="8118" pm="."><plain><bold>Time-dependent spontaneous <italic>cis-trans</italic> isomerization of peptide <italic>p</italic>-aminobenzoyl-CFPVC-(NO<sub>2</sub>)Tyr-NH<sub>2</sub> (<italic>lower curve</italic>) and FkpA-catalyzed <italic>cis-trans</italic> isomerization of peptide <italic>p</italic>-aminobenzoyl-CFPVC-(NO<sub>2</sub>)Tyr-NH<sub>2</sub> (<italic>upper curve</italic>) after reduction of the disulfide bond with DDT.</bold> </plain></SENT>
</text></p></caption><graphic xlink:href="zbc0111151010005"/></fig></SecTag><SecTag type="FIG"><fig id="F6" position="float"><label>FIGURE 6.</label><caption><p><text><SENT sid="8119" pm="."><plain><bold>Determination of <italic>k</italic><sub>cat</sub>/<italic>K<sub>m</sub></italic> of FkpA-catalyzed <italic>cis-trans</italic> isomerization of the Phe-Pro-176 bond in <italic>p</italic>-aminobenzoyl-CFPVC-(NO<sub>2</sub>)Tyr-NH<sub>2</sub>, the Lys-Pro-107 bond in <italic>p</italic>-aminobenzoyl-CKPAC-(NO<sub>2</sub>)Tyr-NH<sub>2</sub>, and the Leu-Pro-260 bond in <italic>p</italic>-aminobenzoyl-CLPGC-(NO<sub>2</sub>)Tyr-NH<sub>2</sub> by measuring the linear dependence of <italic>k</italic><sub>enz</sub> on the concentration of FkpA.</bold> </plain></SENT>
</text></p></caption><graphic xlink:href="zbc0111151010006"/></fig></SecTag><SecTag type="TABLE"><table-wrap id="T5" position="float"><label>TABLE 5</label><caption><p><text><SENT sid="8120" pm="."><plain><bold>Catalysis of prolyl <italic>cis-trans</italic> isomerization of Cma peptides by FkpA, FkpA43, and FkpA313</bold> </plain></SENT>
</text></p><p><text><SENT sid="8121" pm="."><plain>ND, not determined. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead valign="bottom"><tr><th align="center" rowspan="1" colspan="1"><text><SENT sid="8122" pm="."><plain>Cma prolyl bond </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="8123" pm="."><plain><italic>K</italic><sub>cat</sub>/<italic>K<sub>m</sub></italic> FkpA </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="8124" pm="."><plain><italic>K</italic><sub>cat</sub>/<italic>K<sub>m</sub></italic> FkpA43 </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="8125" pm="."><plain><italic>K</italic><sub>cat</sub>/<italic>K<sub>m</sub></italic> FkpA313 </plain></SENT>
</text></th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><text><SENT sid="8126" pm="."><plain><italic><sc>m</sc></italic><sup>−<italic>1</italic></sup><italic>s</italic><sup>−<italic>1</italic></sup> </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="8127" pm="."><plain><italic><sc>m</sc></italic><sup>−<italic>1</italic></sup><italic>s</italic><sup>−<italic>1</italic></sup> </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="8128" pm="."><plain><italic><sc>m</sc></italic><sup>−<italic>1</italic></sup><italic>s</italic><sup>−<italic>1</italic></sup> </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="8129" pm="."><plain>Phe-Pro-176 </plain></SENT>
</text></td><td align="char" char="±" rowspan="1" colspan="1"><text><SENT sid="8130" pm="."><plain>(1.38 ± 0.12) × 10<sup>6</sup> </plain></SENT>
</text></td><td align="char" char="±" rowspan="1" colspan="1"><text><SENT sid="8131" pm="."><plain>(6.61 ± 0.33) × 10<sup>5</sup> </plain></SENT>
</text></td><td align="char" char="±" rowspan="1" colspan="1"><text><SENT sid="8132" pm="."><plain>(3.45 ± 0.43) × 10<sup>3</sup> </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="8133" pm="."><plain>Leu-Pro-260 </plain></SENT>
</text></td><td align="char" char="±" rowspan="1" colspan="1"><text><SENT sid="8134" pm="."><plain>(1.15 ± 0.11) × 10<sup>5</sup> </plain></SENT>
</text></td><td align="char" char="±" rowspan="1" colspan="1"><text><SENT sid="8135" pm="."><plain>(1.34 ± 0.17) × 10<sup>5</sup> </plain></SENT>
</text></td><td align="char" char="±" rowspan="1" colspan="1"><text><SENT sid="8136" pm="."><plain>(5.11 ± 1.44) × 10<sup>3</sup> </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="8137" pm="."><plain>Lys-Pro-107 </plain></SENT>
</text></td><td align="char" char="±" rowspan="1" colspan="1"><text><SENT sid="8138" pm="."><plain>(9.69 ± 0.67) × 10<sup>4</sup> </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8139" pm="."><plain>ND </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8140" pm="."><plain>ND </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag><p><text><SENT sid="8141" pm="."><plain>To further support the role of FkpA PPIase activity for Cma activity, we determined the catalytic efficiency toward the Phe-Pro-176-Val and Leu-Pro-260-Gly derivatives using the FkpA313 mutant protein, which contains a G148D replacement in the PPIase domain and does not mediate Cma sensitivity to cells (<xref ref-type="bibr" rid="B11">11</xref>). </plain></SENT>
<SENT sid="8142" pm="."><plain>Only a very low <italic>in vitro</italic> PPIase activity of FkpA313 was observed with both peptides; the activity amounted to 0.4 and 0.2% that of wild-type FkpA (<xref ref-type="table" rid="T5">Table 5</xref>). </plain></SENT>
<SENT sid="8143" pm="."><plain>The data were further corroborated by the temperature-sensitive mutant FkpA43, which confers 10% activity to Cma at 30 °C and no activity at 42 °C (<xref ref-type="bibr" rid="B11">11</xref>). </plain></SENT>
<SENT sid="8144" pm="."><plain>It displayed a 2-fold lower PPIase activity than wild-type FkpA for Phe-Pro-176-Val and a 5-fold lower activity for Leu-Pro-260-Gly than for Phe-Pro-176-Val (measured at 10 °C) (<xref ref-type="table" rid="T5">Table 5</xref>). </plain></SENT>
<SENT sid="8145" pm="."><plain>The near inactivity of mutant Cma(P176A) in lysing cells and the high efficiency of FkpA in the catalysis of the <italic>cis-trans</italic> isomerization of Phe-Pro-176-Val peptide suggest that Phe-Pro-176 is the Cma peptide bond that is most likely catalytically <italic>cis-trans</italic> isomerized by FkpA. </plain></SENT>
</text></p></sec></sec></sec></sec></SecTag><SecTag type="DISCUSS"><sec sec-type="discussion"><title><text><SENT sid="8146" pm="."><plain>DISCUSSION </plain></SENT>
</text></title><p><text><SENT sid="8147" pm="."><plain>Periplasmic folding helper proteins interact with outer membrane proteins, and a considerable degree of redundancy and overlap in their function is observed (<xref ref-type="bibr" rid="B41">41</xref><xref ref-type="bibr" rid="B42 B43 B44 B45 B46 B47 B48">–</xref><xref ref-type="bibr" rid="B49">49</xref>). </plain></SENT>
<SENT sid="8148" pm="."><plain>For the periplasmic PPIases FkpA, PpiA, PpiD, and SurA of <italic>E. coli</italic>, no specificity for a distinct protein has been found, and no defined prolyl bond of a bacterial protein <italic>cis-trans</italic> isomerized by a PPIase has been identified yet. </plain></SENT>
<SENT sid="8149" pm="."><plain>The strict dependence of Cma toxicity on FkpA allowed us to search for a correlation between Cma activity and FkpA catalysis of <italic>cis-trans</italic> isomerization of a specific prolyl bond of Cma. </plain></SENT>
<SENT sid="8150" pm="."><plain>Using such an approach, we could identify a critical prolyl bond of Cma. </plain></SENT>
</text></p><p><text><SENT sid="8151" pm="."><plain>The 15 Cma proline-to-alanine replacement mutants encompassed all proline residues in Cma. </plain></SENT>
<SENT sid="8152" pm="."><plain>Three mutants showed a strongly reduced (1%) killing of <italic>E. coli</italic>. </plain></SENT>
<SENT sid="8153" pm="."><plain>A fourth mutant, Cma(P107A), had 10% of Cma wild-type activity in plate assays. </plain></SENT>
<SENT sid="8154" pm="."><plain>This mutant was interesting because Pro-107 forms the only prolyl <italic>cis</italic> peptide bond in Cma. </plain></SENT>
<SENT sid="8155" pm="."><plain>Strongly increased activity after bypassing the energy-coupled uptake by osmotic shock suggested that three mutant proteins (Cma(P107A), Cma(P129A), and Cma(P260A)) were impaired in uptake. </plain></SENT>
<SENT sid="8156" pm="."><plain>Indeed, Cma(P129A) did not bind to the FhuA receptor. </plain></SENT>
<SENT sid="8157" pm="."><plain>The translocation efficiency of Cma(P107A) was probably affected by the isomerization of the Lys-Pro <italic>cis</italic> bond to a Lys-Ala <italic>trans</italic> bond even though this conversion altered the protein crystal structure only locally. </plain></SENT>
<SENT sid="8158" pm="."><plain>Because the molecular mechanism of Cma translocation and in fact of any colicin across the outer membrane is unknown, it is not clear to what extent regions other than the translocation domain (residues 1–35) contribute to uptake across the outer membrane. </plain></SENT>
<SENT sid="8159" pm="."><plain>The same reasoning applies to Cma(P260A), whose mutation is not located in the translocation domain but, rather, in the activity domain. </plain></SENT>
</text></p><p><text><SENT sid="8160" pm="."><plain>Cma(P176A) was the only mutant with very low activity (1%) that remained nearly inactive when it was osmotically shocked into cells. </plain></SENT>
<SENT sid="8161" pm="."><plain>It also displayed the lowest activity when it was equipped with a signal sequence, which allowed it to be secreted from the cytoplasm into the periplasm. </plain></SENT>
<SENT sid="8162" pm="."><plain>Because the crystal structure of Cma(P176A) did not differ from the crystal structure of wild-type Cma, it is unlikely that the mutation affects the active center of Cma(P176A). </plain></SENT>
<SENT sid="8163" pm="."><plain>Pro-176 is exposed at the Cma surface (<xref ref-type="fig" rid="F1">Fig. 1</xref>) and its conversion to A176 does not change the Cma structure beyond the mutation site. </plain></SENT>
</text></p><p><text><SENT sid="8164" pm="."><plain>Previous results indicate that Pro-176 is not in the active site of Cma (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B29">29</xref>). </plain></SENT>
<SENT sid="8165" pm="."><plain>Random and site-directed mutagenesis of <italic>cma</italic> localized the active center around residue D226, a strictly conserved residue in a region in which the Cma-type sequences display the highest level of identity (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>). </plain></SENT>
<SENT sid="8166" pm="."><plain>Pro-176 is located far from Asp-226 (<xref ref-type="fig" rid="F1">Fig. 1</xref>). </plain></SENT>
<SENT sid="8167" pm="."><plain>If the P176A mutation affects Cma activity independent of catalysis by FkpA, the mutation must have a long distance structural effect on the active center; such an effect was not observed in the crystal structure. </plain></SENT>
<SENT sid="8168" pm="."><plain>We also found no evidence for a structural alteration of Cma(P176A) in solution; it acted like wild-type Cma with regard to proteinase K digestion, thermal denaturation, and urea denaturation. </plain></SENT>
</text></p><p><text><SENT sid="8169" pm="."><plain>FkpA exhibits PPIase and chaperone activities with artificial substrates (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>). </plain></SENT>
<SENT sid="8170" pm="."><plain>FkpA reactivates Cma denatured with 5 <sc>m</sc> guanidine hydrochloride, which is inhibited by FK506 (<xref ref-type="bibr" rid="B11">11</xref>), an inhibitor of the PPIase activity. </plain></SENT>
<SENT sid="8171" pm="."><plain>In addition, the G148D mutation in the FkpA PPIase center abolishes Cma renaturation (<xref ref-type="bibr" rid="B11">11</xref>) and confers resistance to Cma. </plain></SENT>
<SENT sid="8172" pm="."><plain>Additional mutants in the PPIase domain and only in the PPIase domain, G176D and G180D, were isolated by independent random mutagenesis, which did not confer Cma sensitivity.<xref ref-type="fn" rid="FN4"><sup>3</sup></xref> Arié <italic>et al.</italic> (<xref ref-type="bibr" rid="B13">13</xref>) isolated by site-specific mutagenesis FkpA mutants I174S and I174S/G176S and found no or only 5% PPIase activity but unaltered chaperone activity using a standard protease-coupled peptide assay. </plain></SENT>
<SENT sid="8173" pm="."><plain>These mutants strongly favor the PPIase activity in Cma activation. </plain></SENT>
<SENT sid="8174" pm="."><plain>In this study Phe-Pro-176 is the only bond left for <italic>cis-trans</italic> isomerization. </plain></SENT>
<SENT sid="8175" pm="."><plain>The high catalytic efficiency of FkpA toward the Phe-Pro-176 peptide substrate, which was 14- and 12-fold higher than toward the Lys-Pro-107 and Leu-Pro-260 peptide substrates agrees with this proposal. </plain></SENT>
</text></p><p><text><SENT sid="8176" pm="."><plain>Pro-176 is exposed at the surface of Cma (<xref ref-type="fig" rid="F1">Fig. 1</xref>) and can, thus, be approached by FkpA. </plain></SENT>
<SENT sid="8177" pm="."><plain>Pro-107 and -260 are also close to the surface but are less exposed than Pro-176. </plain></SENT>
<SENT sid="8178" pm="."><plain>Pro-129 is buried inside Cma and cannot be reached by FkpA unless strong structural alterations are induced by binding of Cma to FkpA before catalysis of <italic>cis-trans</italic> isomerization. </plain></SENT>
<SENT sid="8179" pm="."><plain>The location of the Phe-Pro-176 bond makes it the most likely candidate for <italic>cis-trans</italic> isomerization. </plain></SENT>
</text></p><p><text><SENT sid="8180" pm="."><plain>Despite strong evidence for the PPIase activity of FkpA in Cma activation, its chaperone activity should also be considered. </plain></SENT>
<SENT sid="8181" pm="."><plain>Cma(P176A) transferred into the periplasm by osmotic shock did not respond to FkpA as the residual activity was not altered in the <italic>fkpA</italic> deletion mutant (<xref ref-type="table" rid="T4">Table 4</xref>). </plain></SENT>
<SENT sid="8182" pm="."><plain>However, Cma(P176A) secreted from the cytoplasm into the periplasm by a signal sequence fused to Cma(P176A) stopped growth of the <italic>fkpA</italic> wild-type cells and failed to stop growth of the <italic>fkpA</italic> mutant. </plain></SENT>
<SENT sid="8183" pm="."><plain>Although this activity was weak and was only observed after increased synthesis of Cma(P176A), it nevertheless demonstrates some response of Cma(P176A) to FkpA. </plain></SENT>
<SENT sid="8184" pm="."><plain>We assign this activity to the chaperone function of FkpA in the periplasm. </plain></SENT>
<SENT sid="8185" pm="."><plain>However, an exclusive FkpA chaperone activity for activation of Cma would not show such a high site specificity as found for the inactive point mutants in the PPIase domain. </plain></SENT>
</text></p><p><text><SENT sid="8186" pm="."><plain>Cma must unfold at least partially during translocation across the outer membrane and, when fused to a signal sequence, during translocation across the cytoplasmic membrane. </plain></SENT>
<SENT sid="8187" pm="."><plain>Unfolding may convert the Phe-Pro-176 <italic>trans</italic> bond into a <italic>cis</italic> bond. <italic>Trans</italic> to <italic>cis</italic> isomerization also occurred in Cma mutant proteins in which Pro-176 was replaced by Ala, Gly, Leu, Val, Thr, Lys, and Asp. </plain></SENT>
<SENT sid="8188" pm="."><plain>These derivatives were all inactive or nearly inactive because the lack of Pro prevented FkpA-catalized <italic>cis</italic> to <italic>trans</italic> isomerization during refolding in the periplasm. </plain></SENT>
<SENT sid="8189" pm="."><plain>The conversion involves the PPIase, but the chaperone function of FkpA also contributes to Cma activation. </plain></SENT>
<SENT sid="8190" pm="."><plain>Direct determination of the <italic>cis</italic> to <italic>trans</italic> conversion is hampered by the few molecules of Cma in the periplasm, which are sufficient to kill cells (<xref ref-type="bibr" rid="B20">20</xref>) and the much larger unspecific adsorption of Cma to the cells. </plain></SENT>
<SENT sid="8191" pm="."><plain>In addition, we found no suitable wavelength at which fluorescence changes reflected structural changes during <italic>in vitro</italic> refolding of denatured Cma by FkpA (<xref ref-type="bibr" rid="B11">11</xref>). </plain></SENT>
<SENT sid="8192" pm="."><plain>Cma refolding may contribute energy for translocation. </plain></SENT>
<SENT sid="8193" pm="."><plain>In addition, FkpA may act as a chaperone that binds imported Cma and prevents proteolytic degradation of the unfolded protein. </plain></SENT>
<SENT sid="8194" pm="."><plain>Multiple functions of FkpA (Cma refolding, binding of Cma in the periplasm, and positioning of Cma to the substrate site) best explain the complete dependence of Cma activity on FkpA. </plain></SENT>
</text></p></sec></SecTag>
      <SecTag type="SUPPL"><sec sec-type="supplementary-material">
         <title><text><SENT sid="8195" pm="."><plain>Supplementary Material </plain></SENT>
</text></title>
         <supplementary-material id="PMC_1" content-type="local-data">
            <caption>
               <title><text><SENT sid="8196" pm="."><plain>Supplemental Data </plain></SENT>
</text></title>
            </caption>
            <media mimetype="text" mime-subtype="html" xlink:href="supp_286_8_6280__index.html"/>
            <media xlink:role="associated-file" mimetype="application" mime-subtype="pdf" xlink:href="supp_M110.165274_jbc.M110.165274-1.pdf"/>
         </supplementary-material>
      </sec></SecTag>
   </body><back><fn-group><SecTag type="ACK_FUND"><fn fn-type="supported-by" id="FN1"><label>*</label><p><text4fund><text><SENT sid="8197" pm="."><plain>This work was supported by the Max Planck Society, the German Science Foundation (BR 30/25-1), and the Fonds der Chemischen Industrie. </plain></SENT>
</text></text4fund></p></fn></SecTag><SecTag type="SUPPL"><fn fn-type="supplementary-material" id="FN2"><label><inline-graphic xlink:href="sbox.jpg"/></label><p><text><SENT sid="8198" pm="."><plain>The on-line version of this article (available at <ext-link ext-link-type="uri" xlink:href="http://www.jbc.org">http://www.jbc.org</ext-link>) contains <ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M110.165274/DC1">supplemental Figs. S1–S4</ext-link>. </plain></SENT>
</text></p></fn></SecTag><fn fn-type="other"><p><text><SENT sid="8199" pm="."><plain>The atomic coordinates and structure factors (codes <ext-link ext-link-type="uri" xlink:href="http://www.pdb.org/pdb/explore/explore.do?structureId=2XMX">2XMX</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.pdb.org/pdb/explore/explore.do?structureId=2XTR">2XTR</ext-link>) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (<ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/">http://www.rcsb.org/</ext-link>). </plain></SENT>
</text></p></fn><fn fn-type="other" id="FN4"><label>3</label><p><text><SENT sid="8200" pm="."><plain>S. </plain></SENT>
<SENT sid="8201" pm="."><plain>I. </plain></SENT>
<SENT sid="8202" pm="."><plain>Patzer, unpublished results. </plain></SENT>
</text></p></fn></fn-group><fn-group content-type="abbreviations"><fn id="FN3"><label>2</label><p><text><SENT sid="8203" pm="."><plain>The abbreviations used are: <def-list><def-item><term id="G1">Cma</term><def><p>colicin M</p></def></def-item><def-item><term id="G2">PPIase</term><def><p>peptidyl prolyl <italic>cis-trans</italic> isomerase</p></def></def-item><def-item><term id="G3">Ni-NTA</term><def><p>nickel-nitrilotriacetic acid</p></def></def-item><def-item><term id="G4">Bis/Tris</term><def><p>2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol</p></def></def-item><def-item><term id="G5">FKBP</term><def><p>FK506-binding protein.</p></def></def-item></def-list> </plain></SENT>
</text></p></fn></fn-group><SecTag type="ACK_FUND"><ack><title>Acknowledgments</title><p><text4fund><text><SENT sid="8204" pm="."><plain>We thank Dr. Reinhard Albrecht and Kerstin Bär for valuable help in protein crystallization, Dr. Andrei Lupas for generous support, and Karen A. </plain></SENT>
<SENT sid="8205" pm="."><plain>Brune for critically reading the manuscript. </plain></SENT>
<SENT sid="8206" pm="."><plain>We cordially thank the beamline staff from the Max Planck beamline PX10 at the Swiss Light Source for great help and beamline maintenance. </plain></SENT>
</text></text4fund></p></ack></SecTag><SecTag type="REF"><ref-list><title>REFERENCES</title><ref id="B1"><text><SENT sid="8207" pm="."><plain><label>1.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Schaller</surname><given-names>K.</given-names></name><name><surname>Höltje</surname><given-names>J. </plain></SENT>
<SENT sid="8208" pm="."><plain>V.</given-names></name><name><surname>Braun</surname><given-names>V.</given-names></name></person-group> (<year>1982</year>) <source>J. </plain></SENT>
<SENT sid="8209" pm="."><plain>Bacteriol.</source> <volume>152</volume>, <fpage>994</fpage>–<lpage>1000</lpage> <pub-id pub-id-type="pmid">6754708</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B2"><text><SENT sid="8210" pm="."><plain><label>2.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Harkness</surname><given-names>R. </plain></SENT>
<SENT sid="8211" pm="."><plain>E.</given-names></name><name><surname>Braun</surname><given-names>V.</given-names></name></person-group> (<year>1989</year>) <source>J. </plain></SENT>
<SENT sid="8212" pm="."><plain>Biol. </plain></SENT>
<SENT sid="8213" pm="."><plain>Chem.</source> <volume>264</volume>, <fpage>6177</fpage>–<lpage>6182</lpage> <pub-id pub-id-type="pmid">2649496</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B3"><text><SENT sid="8214" pm="."><plain><label>3.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>El Ghachi</surname><given-names>M.</given-names></name><name><surname>Bouhss</surname><given-names>A.</given-names></name><name><surname>Barreteau</surname><given-names>H.</given-names></name><name><surname>Touzé</surname><given-names>T.</given-names></name><name><surname>Auger</surname><given-names>G.</given-names></name><name><surname>Blanot</surname><given-names>D.</given-names></name><name><surname>Mengin-Lecreulx</surname><given-names>D.</given-names></name></person-group> (<year>2006</year>) <source>J. </plain></SENT>
<SENT sid="8215" pm="."><plain>Biol. </plain></SENT>
<SENT sid="8216" pm="."><plain>Chem.</source> <volume>281</volume>, <fpage>22761</fpage>–<lpage>22772</lpage> <pub-id pub-id-type="pmid">16777846</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B4"><text><SENT sid="8217" pm="."><plain><label>4.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Braun</surname><given-names>V.</given-names></name></person-group> (<year>1995</year>) <source>FEMS Microbiol. </plain></SENT>
<SENT sid="8218" pm="."><plain>Rev.</source> <volume>16</volume>, <fpage>295</fpage>–<lpage>307</lpage> <pub-id pub-id-type="pmid">7654405</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B5"><text><SENT sid="8219" pm="."><plain><label>5.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Braun</surname><given-names>V.</given-names></name><name><surname>Patzer</surname><given-names>S. </plain></SENT>
<SENT sid="8220" pm="."><plain>I.</given-names></name><name><surname>Hantke</surname><given-names>K.</given-names></name></person-group> (<year>2002</year>) <source>Biochimie</source> <volume>84</volume>, <fpage>365</fpage>–<lpage>380</lpage> <pub-id pub-id-type="pmid">12423780</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B6"><text><SENT sid="8221" pm="."><plain><label>6.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Postle</surname><given-names>K.</given-names></name><name><surname>Larsen</surname><given-names>R. </plain></SENT>
<SENT sid="8222" pm="."><plain>A.</given-names></name></person-group> (<year>2007</year>) <source>Biometals</source> <volume>20</volume>, <fpage>453</fpage>–<lpage>465</lpage> <pub-id pub-id-type="pmid">17225934</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B7"><text><SENT sid="8223" pm="."><plain><label>7.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Dreher</surname><given-names>R.</given-names></name><name><surname>Braun</surname><given-names>V.</given-names></name><name><surname>Wittmann-Liebold</surname><given-names>B.</given-names></name></person-group> (<year>1985</year>) <source>Arch. </plain></SENT>
<SENT sid="8224" pm="."><plain>Microbiol.</source> <volume>140</volume>, <fpage>343</fpage>–<lpage>346</lpage> <pub-id pub-id-type="pmid">3985748</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B8"><text><SENT sid="8225" pm="."><plain><label>8.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Zeth</surname><given-names>K.</given-names></name><name><surname>Römer</surname><given-names>C.</given-names></name><name><surname>Patzer</surname><given-names>S. </plain></SENT>
<SENT sid="8226" pm="."><plain>I.</given-names></name><name><surname>Braun</surname><given-names>V.</given-names></name></person-group> (<year>2008</year>) <source>J. </plain></SENT>
<SENT sid="8227" pm="."><plain>Biol. </plain></SENT>
<SENT sid="8228" pm="."><plain>Chem.</source> <volume>283</volume>, <fpage>25324</fpage>–<lpage>25331</lpage> <pub-id pub-id-type="pmid">18640984</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B9"><text><SENT sid="8229" pm="."><plain><label>9.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Barreteau</surname><given-names>H.</given-names></name><name><surname>Bouhss</surname><given-names>A.</given-names></name><name><surname>Gérard</surname><given-names>F.</given-names></name><name><surname>Duché</surname><given-names>D.</given-names></name><name><surname>Boussaid</surname><given-names>B.</given-names></name><name><surname>Blanot</surname><given-names>D.</given-names></name><name><surname>Lloubès</surname><given-names>R.</given-names></name><name><surname>Mengin-Lecreulx</surname><given-names>D.</given-names></name><name><surname>Touzé</surname><given-names>T.</given-names></name></person-group> (<year>2010</year>) <source>J. </plain></SENT>
<SENT sid="8230" pm="."><plain>Biol. </plain></SENT>
<SENT sid="8231" pm="."><plain>Chem.</source> <volume>285</volume>, <fpage>12378</fpage>–<lpage>12389</lpage> <pub-id pub-id-type="pmid">20159977</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B10"><text><SENT sid="8232" pm="."><plain><label>10.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Braun</surname><given-names>V.</given-names></name><name><surname>Frenz</surname><given-names>J.</given-names></name><name><surname>Hantke</surname><given-names>K.</given-names></name><name><surname>Schaller</surname><given-names>K.</given-names></name></person-group> (<year>1980</year>) <source>J. </plain></SENT>
<SENT sid="8233" pm="."><plain>Bacteriol.</source> <volume>142</volume>, <fpage>162</fpage>–<lpage>168</lpage> <pub-id pub-id-type="pmid">6989802</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B11"><text><SENT sid="8234" pm="."><plain><label>11.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Hullmann</surname><given-names>J.</given-names></name><name><surname>Patzer</surname><given-names>S. </plain></SENT>
<SENT sid="8235" pm="."><plain>I.</given-names></name><name><surname>Römer</surname><given-names>C.</given-names></name><name><surname>Hantke</surname><given-names>K.</given-names></name><name><surname>Braun</surname><given-names>V.</given-names></name></person-group> (<year>2008</year>) <source>Mol. </plain></SENT>
<SENT sid="8236" pm="."><plain>Microbiol.</source> <volume>69</volume>, <fpage>926</fpage>–<lpage>937</lpage> <pub-id pub-id-type="pmid">18554332</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B12"><text><SENT sid="8237" pm="."><plain><label>12.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Danese</surname><given-names>P. </plain></SENT>
<SENT sid="8238" pm="."><plain>N.</given-names></name><name><surname>Silhavy</surname><given-names>T. </plain></SENT>
<SENT sid="8239" pm="."><plain>J.</given-names></name></person-group> (<year>1997</year>) <source>Genes Dev.</source> <volume>11</volume>, <fpage>1183</fpage>–<lpage>1193</lpage> <pub-id pub-id-type="pmid">9159399</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B13"><text><SENT sid="8240" pm="."><plain><label>13.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Arié</surname><given-names>J. </plain></SENT>
<SENT sid="8241" pm="."><plain>P.</given-names></name><name><surname>Sassoon</surname><given-names>N.</given-names></name><name><surname>Betton</surname><given-names>J. </plain></SENT>
<SENT sid="8242" pm="."><plain>M.</given-names></name></person-group> (<year>2001</year>) <source>Mol. </plain></SENT>
<SENT sid="8243" pm="."><plain>Microbiol.</source> <volume>39</volume>, <fpage>199</fpage>–<lpage>210</lpage> <pub-id pub-id-type="pmid">11123702</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B14"><text><SENT sid="8244" pm="."><plain><label>14.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Bothmann</surname><given-names>H.</given-names></name><name><surname>Pluckthun</surname><given-names>A.</given-names></name></person-group> (<year>2000</year>) <source>J. </plain></SENT>
<SENT sid="8245" pm="."><plain>Biol. </plain></SENT>
<SENT sid="8246" pm="."><plain>Chem.</source> <volume>275</volume>, <fpage>17100</fpage>–<lpage>17105</lpage> <pub-id pub-id-type="pmid">10748200</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B15"><text><SENT sid="8247" pm="."><plain><label>15.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Ramm</surname><given-names>K.</given-names></name><name><surname>Plückthun</surname><given-names>A.</given-names></name></person-group> (<year>2001</year>) <source>J. </plain></SENT>
<SENT sid="8248" pm="."><plain>Mol. </plain></SENT>
<SENT sid="8249" pm="."><plain>Biol.</source> <volume>310</volume>, <fpage>485</fpage>–<lpage>498</lpage> <pub-id pub-id-type="pmid">11428902</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B16"><text><SENT sid="8250" pm="."><plain><label>16.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Saul</surname><given-names>F. </plain></SENT>
<SENT sid="8251" pm="."><plain>A.</given-names></name><name><surname>Arié</surname><given-names>J. </plain></SENT>
<SENT sid="8252" pm="."><plain>P.</given-names></name><name><surname>Vulliez-le Normand</surname><given-names>B.</given-names></name><name><surname>Kahn</surname><given-names>R.</given-names></name><name><surname>Betton</surname><given-names>J. </plain></SENT>
<SENT sid="8253" pm="."><plain>M.</given-names></name><name><surname>Bentley</surname><given-names>G. </plain></SENT>
<SENT sid="8254" pm="."><plain>A.</given-names></name></person-group> (<year>2004</year>) <source>J. </plain></SENT>
<SENT sid="8255" pm="."><plain>Mol. </plain></SENT>
<SENT sid="8256" pm="."><plain>Biol.</source> <volume>335</volume>, <fpage>595</fpage>–<lpage>608</lpage> <pub-id pub-id-type="pmid">14672666</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B17"><text><SENT sid="8257" pm="."><plain><label>17.</label><mixed-citation publication-type="book"> <person-group person-group-type="author"><name><surname>Betton</surname><given-names>J. </plain></SENT>
<SENT sid="8258" pm="."><plain>M.</given-names></name></person-group> (<year>2007</year>) in <source>The Periplasm</source> (<person-group person-group-type="editor"><name><surname>Ehrmann</surname><given-names>M.</given-names></name></person-group> ed) pp. <fpage>141</fpage>–<lpage>149</lpage>, <publisher-name>American Society for Microbiology</publisher-name>, <publisher-loc>Washington, D. </plain></SENT>
<SENT sid="8259" pm="."><plain>C</publisher-loc></mixed-citation> </plain></SENT>
</text></ref><ref id="B18"><text><SENT sid="8260" pm="."><plain><label>18.</label><mixed-citation publication-type="book"> <person-group person-group-type="author"><name><surname>Kleinschmidt</surname><given-names>J. </plain></SENT>
<SENT sid="8261" pm="."><plain>H.</given-names></name></person-group> (<year>2007</year>) in <source>The Periplasm</source> (<person-group person-group-type="editor"><name><surname>Ehrmann</surname><given-names>M.</given-names></name></person-group> ed) pp. <fpage>30</fpage>–<lpage>66</lpage>, <publisher-name>American Society for Microbiology</publisher-name>, <publisher-loc>Washington, D. </plain></SENT>
<SENT sid="8262" pm="."><plain>C</publisher-loc></mixed-citation> </plain></SENT>
</text></ref><ref id="B19"><text><SENT sid="8263" pm="."><plain><label>19.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Mogensen</surname><given-names>J. </plain></SENT>
<SENT sid="8264" pm="."><plain>E.</given-names></name><name><surname>Otzen</surname><given-names>D. </plain></SENT>
<SENT sid="8265" pm="."><plain>E.</given-names></name></person-group> (<year>2005</year>) <source>Mol. </plain></SENT>
<SENT sid="8266" pm="."><plain>Microbiol.</source> <volume>57</volume>, <fpage>326</fpage>–<lpage>346</lpage> <pub-id pub-id-type="pmid">15978068</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B20"><text><SENT sid="8267" pm="."><plain><label>20.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Schaller</surname><given-names>K.</given-names></name><name><surname>Dreher</surname><given-names>R.</given-names></name><name><surname>Braun</surname><given-names>V.</given-names></name></person-group> (<year>1981</year>) <source>J. </plain></SENT>
<SENT sid="8268" pm="."><plain>Bacteriol.</source> <volume>146</volume>, <fpage>54</fpage>–<lpage>63</lpage> <pub-id pub-id-type="pmid">7012126</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B21"><text><SENT sid="8269" pm="."><plain><label>21.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Kabsch</surname><given-names>W.</given-names></name></person-group> (<year>2010</year>) <source>Acta. </plain></SENT>
<SENT sid="8270" pm="."><plain>Crystallogr. </plain></SENT>
<SENT sid="8271" pm="."><plain>D Biol. </plain></SENT>
<SENT sid="8272" pm="."><plain>Crystallogr.</source> <volume>66b</volume>, <fpage>125</fpage>–<lpage>132</lpage><pub-id pub-id-type="pmid">20124692</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B22"><text><SENT sid="8273" pm="."><plain><label>22.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Potterton</surname><given-names>E.</given-names></name><name><surname>Briggs</surname><given-names>P.</given-names></name><name><surname>Turkenburg</surname><given-names>M.</given-names></name><name><surname>Dodson</surname><given-names>E.</given-names></name></person-group> (<year>2003</year>) <source>Acta. </plain></SENT>
<SENT sid="8274" pm="."><plain>Crystallogr. </plain></SENT>
<SENT sid="8275" pm="."><plain>D Biol. </plain></SENT>
<SENT sid="8276" pm="."><plain>Crystallogr.</source> <volume>59</volume>, <fpage>1131</fpage>–<lpage>1137</lpage> <pub-id pub-id-type="pmid">12832755</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B23"><text><SENT sid="8277" pm="."><plain><label>23.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Emsley</surname><given-names>P.</given-names></name><name><surname>Cowtan</surname><given-names>K.</given-names></name></person-group> (<year>2004</year>) <source>Acta. </plain></SENT>
<SENT sid="8278" pm="."><plain>Crystallogr. </plain></SENT>
<SENT sid="8279" pm="."><plain>D Biol. </plain></SENT>
<SENT sid="8280" pm="."><plain>Crystallogr.</source> <volume>60</volume>, <fpage>2126</fpage>–<lpage>2132</lpage> <pub-id pub-id-type="pmid">15572765</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B24"><text><SENT sid="8281" pm="."><plain><label>24.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Laskowski</surname><given-names>R. </plain></SENT>
<SENT sid="8282" pm="."><plain>A.</given-names></name><name><surname>Moss</surname><given-names>D. </plain></SENT>
<SENT sid="8283" pm="."><plain>S.</given-names></name><name><surname>Thornton</surname><given-names>J. </plain></SENT>
<SENT sid="8284" pm="."><plain>M.</given-names></name></person-group> (<year>1993</year>) <source>J. </plain></SENT>
<SENT sid="8285" pm="."><plain>Mol. </plain></SENT>
<SENT sid="8286" pm="."><plain>Biol.</source> <volume>231</volume>, <fpage>1049</fpage>–<lpage>1067</lpage> <pub-id pub-id-type="pmid">8515464</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B25"><text><SENT sid="8287" pm="."><plain><label>25.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Kabsch</surname><given-names>W.</given-names></name><name><surname>Sander</surname><given-names>C.</given-names></name></person-group> (<year>1983</year>) <source>Biopolymers</source> <volume>22</volume>, <fpage>2577</fpage>–<lpage>2637</lpage> <pub-id pub-id-type="pmid">6667333</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B26"><text><SENT sid="8288" pm="."><plain><label>26.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Thumm</surname><given-names>G.</given-names></name><name><surname>Olschläger</surname><given-names>T.</given-names></name><name><surname>Braun</surname><given-names>V.</given-names></name></person-group> (<year>1988</year>) <source>Plasmid</source> <volume>20</volume>, <fpage>75</fpage>–<lpage>82</lpage> <pub-id pub-id-type="pmid">2853881</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B27"><text><SENT sid="8289" pm="."><plain><label>27.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Nossal</surname><given-names>N. </plain></SENT>
<SENT sid="8290" pm="."><plain>G.</given-names></name><name><surname>Heppel</surname><given-names>L. </plain></SENT>
<SENT sid="8291" pm="."><plain>A.</given-names></name></person-group> (<year>1966</year>) <source>J. </plain></SENT>
<SENT sid="8292" pm="."><plain>Biol. </plain></SENT>
<SENT sid="8293" pm="."><plain>Chem.</source> <volume>241</volume>, <fpage>3055</fpage>–<lpage>3062</lpage> <pub-id pub-id-type="pmid">4287907</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B28"><text><SENT sid="8294" pm="."><plain><label>28.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Tilby</surname><given-names>M.</given-names></name><name><surname>Hindennach</surname><given-names>I.</given-names></name><name><surname>Henning</surname><given-names>U.</given-names></name></person-group> (<year>1978</year>) <source>J. </plain></SENT>
<SENT sid="8295" pm="."><plain>Bacteriol.</source> <volume>136</volume>, <fpage>1189</fpage>–<lpage>1191</lpage> <pub-id pub-id-type="pmid">363693</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B29"><text><SENT sid="8296" pm="."><plain><label>29.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Pilsl</surname><given-names>H.</given-names></name><name><surname>Glaser</surname><given-names>C.</given-names></name><name><surname>Gross</surname><given-names>P.</given-names></name><name><surname>Killmann</surname><given-names>H.</given-names></name><name><surname>Olschläger</surname><given-names>T.</given-names></name><name><surname>Braun</surname><given-names>V.</given-names></name></person-group> (<year>1993</year>) <source>Mol. </plain></SENT>
<SENT sid="8297" pm="."><plain>Gen. </plain></SENT>
<SENT sid="8298" pm="."><plain>Genet.</source> <volume>240</volume>, <fpage>103</fpage>–<lpage>112</lpage> <pub-id pub-id-type="pmid">8341256</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B30"><text><SENT sid="8299" pm="."><plain><label>30.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Kadner</surname><given-names>R. </plain></SENT>
<SENT sid="8300" pm="."><plain>J.</given-names></name><name><surname>Heller</surname><given-names>K. </plain></SENT>
<SENT sid="8301" pm="."><plain>J.</given-names></name></person-group> (<year>1995</year>) <source>J. </plain></SENT>
<SENT sid="8302" pm="."><plain>Bacteriol.</source> <volume>177</volume>, <fpage>4829</fpage>–<lpage>4935</lpage> <pub-id pub-id-type="pmid">7665457</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B31"><text><SENT sid="8303" pm="."><plain><label>31.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Harkness</surname><given-names>R. </plain></SENT>
<SENT sid="8304" pm="."><plain>E.</given-names></name><name><surname>Braun</surname><given-names>V.</given-names></name></person-group> (<year>1990</year>) <source>Mol. </plain></SENT>
<SENT sid="8305" pm="."><plain>Gen. </plain></SENT>
<SENT sid="8306" pm="."><plain>Genet.</source> <volume>222</volume>, <fpage>37</fpage>–<lpage>40</lpage> <pub-id pub-id-type="pmid">2233679</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B32"><text><SENT sid="8307" pm="."><plain><label>32.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Olschläger</surname><given-names>T.</given-names></name><name><surname>Turba</surname><given-names>A.</given-names></name><name><surname>Braun</surname><given-names>V.</given-names></name></person-group> (<year>1991</year>) <source>Mol. </plain></SENT>
<SENT sid="8308" pm="."><plain>Microbiol.</source> <volume>5</volume>, <fpage>1105</fpage>–<lpage>1111</lpage> <pub-id pub-id-type="pmid">1956288</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B33"><text><SENT sid="8309" pm="."><plain><label>33.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Gross</surname><given-names>P.</given-names></name><name><surname>Braun</surname><given-names>V.</given-names></name></person-group> (<year>1996</year>) <source>Mol. </plain></SENT>
<SENT sid="8310" pm="."><plain>Gen. </plain></SENT>
<SENT sid="8311" pm="."><plain>Genet.</source> <volume>251</volume>, <fpage>388</fpage>–<lpage>396</lpage> <pub-id pub-id-type="pmid">8676883</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B34"><text><SENT sid="8312" pm="."><plain><label>34.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Olschläger</surname><given-names>T.</given-names></name></person-group> (<year>1991</year>) <source>Arch. </plain></SENT>
<SENT sid="8313" pm="."><plain>Microbiol.</source> <volume>156</volume>, <fpage>449</fpage>–<lpage>454</lpage> <pub-id pub-id-type="pmid">1785952</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B35"><text><SENT sid="8314" pm="."><plain><label>35.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Guzman</surname><given-names>L. </plain></SENT>
<SENT sid="8315" pm="."><plain>M.</given-names></name><name><surname>Belin</surname><given-names>D.</given-names></name><name><surname>Carson</surname><given-names>M. </plain></SENT>
<SENT sid="8316" pm="."><plain>J.</given-names></name><name><surname>Beckwith</surname><given-names>J.</given-names></name></person-group> (<year>1995</year>) <source>J. </plain></SENT>
<SENT sid="8317" pm="."><plain>Bacteriol.</source> <volume>177</volume>, <fpage>4121</fpage>–<lpage>4130</lpage> <pub-id pub-id-type="pmid">7608087</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B36"><text><SENT sid="8318" pm="."><plain><label>36.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Benson</surname><given-names>S. </plain></SENT>
<SENT sid="8319" pm="."><plain>A.</given-names></name><name><surname>Bremer</surname><given-names>E.</given-names></name><name><surname>Silhavy</surname><given-names>T. </plain></SENT>
<SENT sid="8320" pm="."><plain>J.</given-names></name></person-group> (<year>1984</year>) <source>Proc. </plain></SENT>
<SENT sid="8321" pm="."><plain>Natl. </plain></SENT>
<SENT sid="8322" pm="."><plain>Acad. </plain></SENT>
<SENT sid="8323" pm="."><plain>Sci. </plain></SENT>
<SENT sid="8324" pm="."><plain>U.S.A.</source> <volume>81</volume>, <fpage>3830</fpage>–<lpage>3834</lpage> <pub-id pub-id-type="pmid">6374667</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B37"><text><SENT sid="8325" pm="."><plain><label>37.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Schiene-Fischer</surname><given-names>C.</given-names></name><name><surname>Habazettl</surname><given-names>J.</given-names></name><name><surname>Schmid</surname><given-names>F. </plain></SENT>
<SENT sid="8326" pm="."><plain>X.</given-names></name><name><surname>Fischer</surname><given-names>G.</given-names></name></person-group> (<year>2002</year>) <source>Nat. </plain></SENT>
<SENT sid="8327" pm="."><plain>Struct. </plain></SENT>
<SENT sid="8328" pm="."><plain>Biol.</source> <volume>9</volume>, <fpage>419</fpage>–<lpage>424</lpage> <pub-id pub-id-type="pmid">12021775</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B38"><text><SENT sid="8329" pm="."><plain><label>38.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Fischer</surname><given-names>G.</given-names></name><name><surname>Aumüller</surname><given-names>T.</given-names></name></person-group> (<year>2003</year>) <source>Rev. </plain></SENT>
<SENT sid="8330" pm="."><plain>Physiol. </plain></SENT>
<SENT sid="8331" pm="."><plain>Biochem. </plain></SENT>
<SENT sid="8332" pm="."><plain>Pharmacol.</source> <volume>148</volume>, <fpage>105</fpage>–<lpage>150</lpage> <pub-id pub-id-type="pmid">12698322</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B39"><text><SENT sid="8333" pm="."><plain><label>39.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Weisshoff</surname><given-names>H.</given-names></name><name><surname>Frost</surname><given-names>K.</given-names></name><name><surname>Brandt</surname><given-names>W.</given-names></name><name><surname>Henklein</surname><given-names>P.</given-names></name><name><surname>Mügge</surname><given-names>C.</given-names></name><name><surname>Frömmel</surname><given-names>C.</given-names></name></person-group> (<year>1995</year>) <source>FEBS Lett.</source> <volume>372</volume>, <fpage>203</fpage>–<lpage>209</lpage> <pub-id pub-id-type="pmid">7556670</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B40"><text><SENT sid="8334" pm="."><plain><label>40.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Harrison</surname><given-names>R. </plain></SENT>
<SENT sid="8335" pm="."><plain>K.</given-names></name><name><surname>Stein</surname><given-names>R. </plain></SENT>
<SENT sid="8336" pm="."><plain>L.</given-names></name></person-group> (<year>1990</year>) <source>Biochemistry</source> <volume>29</volume>, <fpage>3813</fpage>–<lpage>3816</lpage> <pub-id pub-id-type="pmid">1693856</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B41"><text><SENT sid="8337" pm="."><plain><label>41.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Chen</surname><given-names>R.</given-names></name><name><surname>Henning</surname><given-names>U.</given-names></name></person-group> (<year>1996</year>) <source>Mol. </plain></SENT>
<SENT sid="8338" pm="."><plain>Microbiol.</source> <volume>19</volume>, <fpage>1287</fpage>–<lpage>1294</lpage> <pub-id pub-id-type="pmid">8730870</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B42"><text><SENT sid="8339" pm="."><plain><label>42.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Justice</surname><given-names>S. </plain></SENT>
<SENT sid="8340" pm="."><plain>S.</given-names></name><name><surname>Hunstad</surname><given-names>D. </plain></SENT>
<SENT sid="8341" pm="."><plain>A.</given-names></name><name><surname>Harper</surname><given-names>J. </plain></SENT>
<SENT sid="8342" pm="."><plain>R.</given-names></name><name><surname>Duguay</surname><given-names>A. </plain></SENT>
<SENT sid="8343" pm="."><plain>R.</given-names></name><name><surname>Pinkner</surname><given-names>J. </plain></SENT>
<SENT sid="8344" pm="."><plain>S.</given-names></name><name><surname>Bann</surname><given-names>J.</given-names></name><name><surname>Frieden</surname><given-names>C.</given-names></name><name><surname>Silhavy</surname><given-names>T. </plain></SENT>
<SENT sid="8345" pm="."><plain>J.</given-names></name><name><surname>Hultgren</surname><given-names>S. </plain></SENT>
<SENT sid="8346" pm="."><plain>J.</given-names></name></person-group> (<year>2005</year>) <source>J. </plain></SENT>
<SENT sid="8347" pm="."><plain>Bacteriol.</source> <volume>187</volume>, <fpage>7680</fpage>–<lpage>7686</lpage> <pub-id pub-id-type="pmid">16267292</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B43"><text><SENT sid="8348" pm="."><plain><label>43.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Qu</surname><given-names>J.</given-names></name><name><surname>Mayer</surname><given-names>C.</given-names></name><name><surname>Behrens</surname><given-names>S.</given-names></name><name><surname>Holst</surname><given-names>O.</given-names></name><name><surname>Kleinschmidt</surname><given-names>J. </plain></SENT>
<SENT sid="8349" pm="."><plain>H.</given-names></name></person-group> (<year>2007</year>) <source>J. </plain></SENT>
<SENT sid="8350" pm="."><plain>Mol. </plain></SENT>
<SENT sid="8351" pm="."><plain>Biol.</source> <volume>374</volume>, <fpage>91</fpage>–<lpage>105</lpage> <pub-id pub-id-type="pmid">17928002</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B44"><text><SENT sid="8352" pm="."><plain><label>44.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Rizzitello</surname><given-names>A. </plain></SENT>
<SENT sid="8353" pm="."><plain>E.</given-names></name><name><surname>Harper</surname><given-names>J. </plain></SENT>
<SENT sid="8354" pm="."><plain>R.</given-names></name><name><surname>Silhavy</surname><given-names>T. </plain></SENT>
<SENT sid="8355" pm="."><plain>J.</given-names></name></person-group> (<year>2001</year>) <source>J. </plain></SENT>
<SENT sid="8356" pm="."><plain>Bacteriol.</source> <volume>183</volume>, <fpage>6794</fpage>–<lpage>6800</lpage> <pub-id pub-id-type="pmid">11698367</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B45"><text><SENT sid="8357" pm="."><plain><label>45.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Rouvière</surname><given-names>P. </plain></SENT>
<SENT sid="8358" pm="."><plain>E.</given-names></name><name><surname>Gross</surname><given-names>C. </plain></SENT>
<SENT sid="8359" pm="."><plain>A.</given-names></name></person-group> (<year>1996</year>) <source>Genes Dev.</source> <volume>10</volume>, <fpage>3170</fpage>–<lpage>3182</lpage> <pub-id pub-id-type="pmid">8985185</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B46"><text><SENT sid="8360" pm="."><plain><label>46.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Schäfer</surname><given-names>U.</given-names></name><name><surname>Beck</surname><given-names>K.</given-names></name><name><surname>Müller</surname><given-names>M.</given-names></name></person-group> (<year>1999</year>) <source>J. </plain></SENT>
<SENT sid="8361" pm="."><plain>Biol. </plain></SENT>
<SENT sid="8362" pm="."><plain>Chem.</source> <volume>274</volume>, <fpage>24567</fpage>–<lpage>24574</lpage> <pub-id pub-id-type="pmid">10455120</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B47"><text><SENT sid="8363" pm="."><plain><label>47.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Sklar</surname><given-names>J. </plain></SENT>
<SENT sid="8364" pm="."><plain>G.</given-names></name><name><surname>Wu</surname><given-names>T.</given-names></name><name><surname>Kahne</surname><given-names>D.</given-names></name><name><surname>Silhavy</surname><given-names>T. </plain></SENT>
<SENT sid="8365" pm="."><plain>J.</given-names></name></person-group> (<year>2007</year>) <source>Genes Dev.</source> <volume>21</volume>, <fpage>2473</fpage>–<lpage>2484</lpage> <pub-id pub-id-type="pmid">17908933</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B48"><text><SENT sid="8366" pm="."><plain><label>48.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Stymest</surname><given-names>K. </plain></SENT>
<SENT sid="8367" pm="."><plain>H.</given-names></name><name><surname>Klappa</surname><given-names>P.</given-names></name></person-group> (<year>2008</year>) <source>FEBS</source> <volume>275</volume>, <fpage>3470</fpage>–<lpage>3479</lpage> </mixed-citation> </plain></SENT>
</text></ref><ref id="B49"><text><SENT sid="8368" pm="."><plain><label>49.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Vertommen</surname><given-names>D.</given-names></name><name><surname>Ruiz</surname><given-names>N.</given-names></name><name><surname>Leverrier</surname><given-names>P.</given-names></name><name><surname>Silhavy</surname><given-names>T. </plain></SENT>
<SENT sid="8369" pm="."><plain>J.</given-names></name><name><surname>Collet</surname><given-names>J. </plain></SENT>
<SENT sid="8370" pm="."><plain>F.</given-names></name></person-group> (<year>2009</year>) <source>Proteomics</source> <volume>9</volume>, <fpage>2432</fpage>–<lpage>2443</lpage> <pub-id pub-id-type="pmid">19343722</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B50"><text><SENT sid="8371" pm="."><plain><label>50.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Studier</surname><given-names>F. </plain></SENT>
<SENT sid="8372" pm="."><plain>W.</given-names></name><name><surname>Moffatt</surname><given-names>B. </plain></SENT>
<SENT sid="8373" pm="."><plain>A.</given-names></name></person-group> (<year>1986</year>) <source>J. </plain></SENT>
<SENT sid="8374" pm="."><plain>Mol. </plain></SENT>
<SENT sid="8375" pm="."><plain>Biol.</source> <volume>189</volume>, <fpage>113</fpage>–<lpage>130</lpage> <pub-id pub-id-type="pmid">3537305</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B51"><text><SENT sid="8376" pm="."><plain><label>51.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Mende</surname><given-names>J.</given-names></name><name><surname>Braun</surname><given-names>V.</given-names></name></person-group> (<year>1990</year>) <source>Mol. </plain></SENT>
<SENT sid="8377" pm="."><plain>Microbiol.</source> <volume>4</volume>, <fpage>1523</fpage>–<lpage>1533</lpage> <pub-id pub-id-type="pmid">2287276</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B52"><text><SENT sid="8378" pm="."><plain><label>52.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Hanahan</surname><given-names>D.</given-names></name></person-group> (<year>1983</year>) <source>J. </plain></SENT>
<SENT sid="8379" pm="."><plain>Mol. </plain></SENT>
<SENT sid="8380" pm="."><plain>Biol.</source> <volume>166</volume>, <fpage>557</fpage>–<lpage>580</lpage> <pub-id pub-id-type="pmid">6345791</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B53"><text><SENT sid="8381" pm="."><plain><label>53.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Tabor</surname><given-names>S.</given-names></name><name><surname>Richardson</surname><given-names>C. </plain></SENT>
<SENT sid="8382" pm="."><plain>C.</given-names></name></person-group> (<year>1985</year>) <source>Proc. </plain></SENT>
<SENT sid="8383" pm="."><plain>Natl. </plain></SENT>
<SENT sid="8384" pm="."><plain>Acad. </plain></SENT>
<SENT sid="8385" pm="."><plain>Sci. </plain></SENT>
<SENT sid="8386" pm="."><plain>U.S.A.</source> <volume>82</volume>, <fpage>1074</fpage>–<lpage>1078</lpage> <pub-id pub-id-type="pmid">3156376</pub-id></mixed-citation> </plain></SENT>
</text></ref><ref id="B54"><text><SENT sid="8387" pm="."><plain><label>54.</label><mixed-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Braun</surname><given-names>M.</given-names></name><name><surname>Endriss</surname><given-names>F.</given-names></name><name><surname>Killmann</surname><given-names>H.</given-names></name><name><surname>Braun</surname><given-names>V.</given-names></name></person-group> (<year>2003</year>) <source>J. </plain></SENT>
<SENT sid="8388" pm="."><plain>Bacteriol.</source> <volume>185</volume>, <fpage>5508</fpage>–<lpage>5518</lpage><pub-id pub-id-type="pmid">12949103</pub-id></mixed-citation> </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
